TOLUENE
HAZARDTEXT ®
Information to help in the initial response for evaluating chemical incidents
-IDENTIFICATION
SYNONYMS
TOLUENE ANTISAL 1a BENZENE, METHYL- CP 25 METHACIDE METHANE, PHENYL- METHYL BENZENE METHYL-BENZENE METHYLBENZENE METHYL BENZOL METHYLBENZOL MONOMETHYL BENZENE PHENYL METHANE PHENYLMETHANE TOL TOLUEEN (Dutch) TOLUEN (Czech) TOLUENO (Spanish) TOLUOL TOLUOLO (Italian) TOLU-SOL ETHYLENEBENZENE TOLUEEN TOLUEN TOLUENO TOLUOLO
IDENTIFIERS
49 093 56 - Toluene (toluol), reclaimed solvents, derived from the use of printing inks, consisting of 70% recycled toluol and not more than 30% lactol spirits, textile spirits and mineral spirits 49 060 10 - Toluene (toluol), mixed with aluminum alkyls, not to exceed 20% (aluminum alkyl) 49 093 05 - Toluene
SYNONYM REFERENCE
- (Ashford, 1994; Bingham et al, 2001; Budavari, 2000; CHRIS , 2002; HSDB , 2002; NIOSH, 2002; Lewis, 2000; OHM/TADS , 2002; RTECS , 2002)
USES/FORMS/SOURCES
Toluene is used in the manufacture of benzene, benzyl chloride, toluene diisocyanate, benzoic acid, benzaldehyde, explosives (TNT), dyes, and many other organic compounds. It is also used as a solvent for rubber, oil, adhesives, inks, detergents, dyes, paints, lacquers, gums, resins, in the extraction of various principles from plants, in pharmaceuticals, and as an additive to increase fuel and gasoline octane ratings. It is also used as a nonclinical thermometer liquid (ACGIH, 1991; Bingham et al, 2001; Budavari, 2000; Hathaway et al, 1996; Lewis, 1997; Verschueren, 2001). Approximately 11%of the total toluene produced in the United States is isolated as toluene. Most is produced and used in a mixture of benzene, toluene and xylene as a gasoline additive to increase octane rating (Bingham et al, 2001).
Toluene is a highly volatile and colorless, clear, refractive liquid with a sweet, pungent, aromatic odor (Budavari, 2000; CHRIS , 2002). Its odor has also been described as a sour, burnt smell (Verschueren, 2001). Toluene is available commercially in nitration, industrial, and reagent grades (ACGIH, 1991).
Toluene is isolated through the petroleum catalytic conversion reforming reactions of C6 to C9 naphthas and sulfolane extraction (Bingham et al, 2001; ACGIH, 1991). It is a monomethyl derivative of benzene (Baxter et al, 2000). Reforming of n-heptane at 977 degrees C yields approximately 62% toluene (Bingham et al, 2001). Toluene occurs naturally in crude oil and in the tolu tree (ATSDR, 2001). It has been detected in natural gas deposits, volcanic emissions and forest fires (HSDB , 2002).
-CLINICAL EFFECTS
GENERAL CLINICAL EFFECTS
- USES: Toluene (toluol, methyl benzene) is an aromatic petroleum hydrocarbon that has many commercial and industrial applications. It is used as a solvent and starting material for organic synthesis and is found in paints, paint thinners, glues, and other products. Toluene products are abused via inhalation for their intoxicating effects.
- TOXICOLOGY: It has long been held that toluene's effect on the central nervous system are via nonspecific lipophilic membrane interactions, which in turn modulates several neurotransmitter systems (ie, dopamine, acetylcholine, GABA, glycine, and serotonin).
- EPIDEMIOLOGY: Exposures are common, but significant toxicity is generally only seen in the setting of deliberate inhalation abuse and deaths are rare.
MILD TO MODERATE TOXICITY: Acute ingestion causes CNS depression, oropharyngeal and gastric pain and vomiting. Splash exposure to eyes may cause irritation, burning, blepharospasm, conjunctivitis, corneal edema, and corneal abrasions. Symptoms usually resolve within 48 hours. Prolonged or repeated dermal exposures may result in a defatting dermatitis. Occupational exposure has been linked to an increased risk of esophageal and rectal cancers as well as increased mortality from bone and connective tissue cancers. SEVERE TOXICITY: Acute inhalation produces a biphasic response with an initial CNS excitation followed by CNS depression, which is characterized by ataxia, fatigue, sedation, occasionally seizures, and at very high concentrations general anesthesia. Sudden death may occur from hypoxia or cardiac dysrhythmias. Chronic inhalational abuse is associated with muscular weakness, gastrointestinal symptoms (pain, nausea, vomiting), renal tubular acidosis (hypokalemia and metabolic acidosis), hepatic injury, and neuropsychiatric symptoms. Patients who chronically abuse toluene may exhibit hypokalemia, hematuria, proteinuria, oliguria, paresis, rhabdomyolysis, hallucinations, hyperactive reflexes, peripheral neuropathy, personality changes, tremors, headaches, emotional lability, and memory loss. Patients with long-term inhalational abuse may develop progressive irreversible encephalopathy with cognitive difficulty and cerebellar ataxia. Significant inhalational exposure causes an easily recognized odor to the breath that may persist for several days after exposure ceases. There are a small number of case reports of mothers who regularly abused toluene recreationally during pregnancy giving birth to children with microcephaly, CNS dysfunction, and minor head, face and limb anomalies. However, some of these mothers also abused ethanol as well.
- POTENTIAL HEALTH HAZARDS - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 130 (ERG, 2004)
May cause toxic effects if inhaled or absorbed through skin. Inhalation or contact with material may irritate or burn skin and eyes. Fire will produce irritating, corrosive and/or toxic gases. Vapors may cause dizziness or suffocation. Runoff from fire control or dilution water may cause pollution.
ACUTE CLINICAL EFFECTS
TOXICOLOGY: It has long been held that toluene's effect on the central nervous system are via nonspecific lipophilic membrane interactions, which in turn modulates several neurotransmitter systems (ie, dopamine, acetylcholine, GABA, glycine, and serotonin). EPIDEMIOLOGY: Exposures are common, but significant toxicity is generally only seen in the setting of deliberate inhalation abuse and deaths are rare.
MILD TO MODERATE TOXICITY: Acute ingestion causes CNS depression, oropharyngeal and gastric pain and vomiting. Splash exposure to eyes may cause irritation, burning, blepharospasm, conjunctivitis, corneal edema, and corneal abrasions. Symptoms usually resolve within 48 hours. Prolonged or repeated dermal exposures may result in a defatting dermatitis. Occupational exposure has been linked to an increased risk of esophageal and rectal cancers as well as increased mortality from bone and connective tissue cancers. SEVERE TOXICITY: Acute inhalation produces a biphasic response with an initial CNS excitation followed by CNS depression, which is characterized by ataxia, fatigue, sedation, occasionally seizures, and at very high concentrations general anesthesia. Sudden death may occur from hypoxia or cardiac dysrhythmias. Chronic inhalational abuse is associated with muscular weakness, gastrointestinal symptoms (pain, nausea, vomiting), renal tubular acidosis (hypokalemia and metabolic acidosis), hepatic injury, and neuropsychiatric symptoms. Patients who chronically abuse toluene may exhibit hypokalemia, hematuria, proteinuria, oliguria, paresis, rhabdomyolysis, hallucinations, hyperactive reflexes, peripheral neuropathy, personality changes, tremors, headaches, emotional lability, and memory loss. Patients with long-term inhalational abuse may develop progressive irreversible encephalopathy with cognitive difficulty and cerebellar ataxia. Significant inhalational exposure causes an easily recognized odor to the breath that may persist for several days after exposure ceases. There are a small number of case reports of mothers who regularly abused toluene recreationally during pregnancy giving birth to children with microcephaly, CNS dysfunction, and minor head, face and limb anomalies. However, some of these mothers also abused ethanol as well.
METABOLIC ACIDOSIS: Hyperchloremic metabolic acidosis is a common presenting finding in hospitalized toluene abusers; 76% to 100% of paint sniffers in 2 small case series presented with metabolic acidosis (Tsao et al, 2011; Streicher et al, 1981; Voights & Kaufman, 1983). Other cases of paint sniffing have also shown metabolic acidosis on admission (Voights & Kaufman, 1983). MECHANISM: Toluene inhalation causes metabolic acidosis due to tissue hypoxia, distal renal tubular acidosis, and accumulation of its metabolites, benzoic and hippuric acids.
CARDIAC DYSRHYTHMIA: Sudden death after acute inhalation (usually in chronic abusers) is occasionally due to fatal dysrhythmias possibly secondary to sensitization to endogenous catecholamines (Bingham et al, 2001; Carlsson, 1982). Sinus bradycardia (Einav et al, 1997), ventricular fibrillation and myocardial infarction (Carder & Fuerst, 1997; Hussain et al, 1996; Cunningham et al, 1987) have been reported. CARDIOMYOPATHY: Isolated cases of dilated cardiomyopathy have been reported in chronic toluene abusers (Wiseman & Banim, 1987; Mee & Wright, 1980). HYPERTENSION EPISODE: A 46-year-old man presented to the emergency department with a blood pressure of 147/92 mmHg 30 minutes after ingestion of approximately 1 quart of a paint thinner that contained toluene (Caravati & Bjerk, 1997). HYPOTENSION: A 34-year-old man presented to the hospital with a systolic blood pressure of 60 mmHg and a pulse of 45 beats/minute after an acute inhalation of paint thinner containing 50% toluene (Einav et al, 1997). ECG ABNORMALITIES: ECG abnormalities (ie, first degree AV-block, AV dissociation with junctional escape beat) can occur and have been reported in patients exposed to toluene inhalants (Tsao et al, 2011; Einav et al, 1997).
DERMATITIS: After prolonged contact with skin, toluene may cause drying and defatting, which results in fissured dermatitis (Bingham et al, 2001; HSDB , 2002). CHEMICAL BURN: Isolated cases of chemical burns have been reported in patients who were exposed to toluene-containing liquids (Reisin et al, 1975), which can result in significant toxicity and even death following extensive burns (Shibata et al, 1994).
Studies in toluene exposed workers have demonstrated lower levels of follicle stimulating hormone, luteinizing hormone, and testosterone (Svensson et al, 1992; Svensson et al, 1992a).
Hypokalemia, metabolic acidosis and hypophosphatemia are typical, with greater severity in those presenting with the muscular weakness syndrome. Hypercalcemia and hypouricemia are less frequent (Karmakar & Roxburgh, 2008; Gummin & Hryhorczuk, 2006; Kamijo et al, 1998). HYPERCALCEMIA: Hypercalcemia and hypercalcuria may occur secondary to bone loss during metabolic acidosis. Renal calculi may occur, especially in patients with an alkaline urine, due to precipitation of calcium phosphate (Kroeger et al, 1980).
GASTROINTESTINAL FINDINGS: One of the main presenting syndromes in chronic toluene abusers is gastrointestinal, with abdominal pain, nausea, vomiting, and/or hematemesis (HSDB , 2002; Streicher et al, 1981).
RENAL TUBULAR ACIDOSIS: Transient distal renal tubular acidosis (RTA) may be found in up to 44% of paint sniffers who have been hospitalized (Voigts & Kaufman, 1983). Hyperchloremic metabolic acidosis, hypokalemia and urine pH greater than 5.5 are found, usually accompanied by rapidly reversible renal insufficiency (Voights & Kaufman, 1983a; Kamijo et al, 1998). Proximal renal tubular acidosis is less common (Voights & Kaufman, 1983; Streicher et al, 1981) COMPLICATIONS: Severe muscle weakness (often quadriparesis) due to profound hypokalemia often dominates the clinical presentation (Streicher et al, 1981; Kamijo et al, 1998). ACUTE RENAL FAILURE: Isolated cases of acute renal failure secondary to interstitial nephritis, myoglobinuria, or acute toxic tubular necrosis have been reported after workplace exposure, accidental ingestion, and glue sniffing (Voights & Kaufman, 1983; Gupta et al, 1991). GLOMERULONEPHRITIS: Isolated cases of glomerulonephritis have been reported in patients exposed to toluene in both the work setting (Bosch et al, 1988) and through glue sniffing (Bonzel et al, 1987). MENSTRUAL ABNORMALITIES: Menstrual abnormalities and uterine or vaginal prolapse have been reported in female workers exposed to toluene (CESARS , 1990; Ng et al, 1992). Other abnormalities reported included dysmenorrhea (Snyder, 1987), hypermenorrhea, and polymenorrhea (CESARS , 1990; Ng et al, 1992). UTERINE PROLAPSE: An increased incidence of uterine and vaginal wall prolapse occurred in female workers exposed to toluene compared with a control group (CESARS , 1990).
HEARING LOSS: Although data are limited, toluene is considered an ototoxin that has the potential to cause irreversible hearing loss (Goldfrank, 1998). Two cases of hearing loss have been reported in humans after chronic inhalation abuse (Williams, 1988; Ehyai & Freemon, 1983). Toluene may also be ototoxic with chronic occupational exposure (Morata et al, 1994; Morata et al, 1997). OCULAR IRRITATION: Toluene is a strong eye irritant, causing reversible superficial injury after splash contact, healing within 48 hours. Findings include immediate, severe burning pain, blepharospasm, moderate conjunctival hyperemia, and corneal edema (Grant & Schuman, 1993; Lewis, 2000). With chronic inhalation exposure, decreased color discrimination, optic atrophy with blindness, and pendular nystagmus (in patients with atrophy or visual dysfunction) have been reported (Ehyai & Freemon, 1983; Maas et al, 1991). OPTIC NEUROPATHY: Optic neuropathy resulting from exposure has been documented to produce bilateral vision loss (Baxter et al, 2000). Optic atrophy with sensorineural hearing loss has also been described in specific cases (Ehyai & Freemon, 1983; Williams, 1988). NYSTAGMUS: Ocular flutter, opsoclonus and dysmetria have been associated with toluene exposure (Baxter et al, 2000). DECREASED COLOR DISCRIMINATION: Decreased color discrimination and decreased accuracy in visual perception were reported in printers exposed to 100 parts/million, after having been exposed to solvents for 9 to 25 years (CESARS , 1990). ABNORMAL VISUAL POTENTIALS: Abnormalities in visual evoked potentials (greater amplitudes) were demonstrated in toluene exposed workers in one study (Vrca et al, 1995).
MYELOSUPPRESSION: Hematological abnormalities including bone marrow dysplasia (Hathaugy et al, 1991) and anemia (Snyder, 1987; Bosch et al, 1988) have been reported in patients exposed to toluene. COAGULOPATHY: Increased coagulation time and hypoprothrombinemia were reported in workers in a pharmaceutical plant (Clayton & Clayton, 1981).
HEPATIC FAILURE: Hepatorenal failure has been reported in cases of toluene abuse and occupational exposure (O'Brien et al, 1971; Taverner et al, 1988; Knight et al, 1991). HEPATOMEGALY: Hepatomegaly has been documented in cases of toluene exposure (Baxter et al, 2000; Zenz, 1994). LIVER STEATOSIS: Fatty liver and increased ALT/AST ratio has been associated with chronic workplace exposure, but concurrent alcohol use has been a confounding variable and a cause-effect relationship is unproven; alcoholism increased the risk of severe steatosis in animal studies (Guzelian et al, 1988; Howell et al, 1986; Shiomi et al, 1993).
RHABDOMYOLYSIS: Rhabdomyolysis is present in as many as 40% of chronic toluene abusers, secondary to hypokalemia, hypophosphatemia, compression ischemia in comatose patients, or direct muscle toxicity (Karmakar & Roxburgh, 2008; Shannon, 1987; Streicher et al, 1981). MUSCLE WEAKNESS: Muscle weakness has been reported amongst patients who were admitted with symptoms from paint sniffing (Streicher et al, 1981). HYPOTONIC MUSCLE TONE was noted in a habitual toluene sniffer. Muscle atrophy and weakness were not seen (HSDB , 2002).
CNS EXCITATION: Transient CNS excitation (ie, euphoria, giddiness, tremors, nervousness, insomnia) followed by CNS depression is common after exposure to 400 to 800 parts/million (Snyder, 1987). Chronic exposure has led to hyperreflexia and tremors (HSDB , 2002; CESARS , 1990). CNS DEPRESSION: Even with reported CNS excitation, toluene is a central nervous system depressant in animals and humans (ACGIH, 1991). CNS depression follows excitation after exposure to 400 to 800 parts per million, with signs/symptoms of headache, dizziness, fatigue, drowsiness, lassitude, confusion, hilarity, vertigo, increased reaction time, and perceptual speed (ACGIH, 1991). ATAXIA: Intentional inhalational abuse, with very high concentrations, can result in cerebellar ataxia and cognitive dysfunction (ACGIH, 1991). The effects can be severe and are likely to be permanent in individuals with a history of chronic misuse (ie, glue sniffing) (Karmakar & Roxburgh, 2008). Reversible acute behavioral effects after a single toluene inhalation exposure to over 100 parts per million may be a sign of CNS impairment leading to irreversible performance loss with repeated exposure (Escheverria et al, 1989). ENCEPHALOPATHY: Progressive, irreversible mixed encephalopathy with cognitive difficulty and cerebellar ataxia, and organic affective syndromes have occurred after chronic workplace or abuse exposures (HSDB , 2002; Larsen & Leira, 1988). Permanent encephalopathy was reported in a man who inhaled toluene regularly for over 14 years (HSDB , 2002). RADIOGRAPHIC CHANGES: MRI of chronic abusers showed abnormal gray-white differentiation, with white matter changes consistent with disruption of myelin (Maas et al, 1991; Rosenberg et al, 1988). SECONDARY PERIPHERAL NEUROPATHY: Patients have developed peripheral neuropathy following hospitalization for sniffing paints (Streicher et al, 1981). The onset has been reported months to years after chronic abuse (King et al, 1985; Shannon, 1987). In some cases, the neuropathy has been attributed to other ingredients in the glue (hexane, methyl ethyl ketone) or concurrent drug abuse (Snyder, 1987). SEIZURE: Isolated cases of grand mal epilepsy, status epilepticus, choreoathetosis, temporal lobe epilepsy, and opisthotonus have been reported in chronic abusers of toluene (Arthur & Curnock, 1982; Bartolucci & Pellettier, 1984; Byrne & Zibin, 1991). HYPERREFLEXIA: Cases of hyperreflexia have been reported in patients exposed chronically to toluene. Manifestations included postural tremor of the fingers with rhythmic myoclonic jerks of the right upper limb (Sugiyama-Oishi et al, 2000) and hyperactive muscle stretch reflexes with unsustained clonus at the ankles (CESARS , 1990). Bilateral Babinski signs were also present (CESARS , 1990). DIZZINESS: Dizziness has been reported in toluene-exposed workers (Ukai et al, 1993).
PSYCHOTIC DISORDER: A male worker exposed to toluene for 5 years was diagnosed with undifferentiated schizophrenia with loosening of associations. It was concluded that toluene was associated with an irreversible schizophreniform psychosis (CESARS , 1990). In a review of 22 patients with a history of chronic solvent abuse (mainly toluene in 21 cases), acute paranoid psychosis with auditory and visual hallucinations was diagnosed in 18 patients. A confused state accompanied the psychosis in 16 patients (Byrne & Zibin, 1991). DEPRESSION: Major depression coinciding with toluene exposure has been reported (Levy et al, 1994).
RESPIRATORY FAILURE: Patients have presented with respiratory failure following exposure to toluene inhalants (Chowdhury, 1977; Cronk et al, 1985). PNEUMONITIS: Chemical pneumonitis has been reported after aspiration (Snyder, 1987) and in one patient that had been lying in toluene for an estimated 18 hours (Reisin et al, 1975). ASPHYXIATION: Toluene abusers may asphyxiate while inhaling from a plastic bag (CESARS , 1990). BRONCHOSPASM: An obstructive ventilatory pattern was present in 9 of 10 subjects who had abused spray paint for an average of 34.9 months (Reyes de la Roche et al, 1987). BRADYPNEA, CASE REPORT: A 34-year-old man, chronically addicted to paint thinner, presented to the hospital with a respiratory rate of 6 breaths/minute, hypotension, and a pulse of 45 beats/minute after an acute inhalation of paint thinner containing 50% toluene (Einav et al, 1997).
CHRONIC CLINICAL EFFECTS
- Repeated exposure to toluene has a CUMULATIVE EFFECT on the nervous system (Basu, 1982). Irritation of mucous membranes, headaches, dizziness, nausea, loss of appetite, and intolerance to alcohol have been reported with chronic toluene exposure (ILO, 1983).
- Hepatotoxicity and nephrotoxicity, as well as severe muscle weakness, cardiac arrhythmias, and gastrointestinal and neuropsychiatric problems, may result from chronic inhalation exposure (Budavari, 1996). Repeated or prolonged contact of the liquid with the skin can cause defatting dermatitis (Hathaway et al, 1996).
- Chronic exposure of 50 to 200 ppm has been associated with headache, lassitude, and nausea, whereas exposure to 200 to 500 ppm has produced loss of coordination, memory loss, and loss of appetite (ACGIH, 1991). Painters exposed to 100 to 1,100 ppm had a moderate decrease in red blood cells, with no effect on white blood cell counts (ACGIH, 1991). At 500 to 1,500 ppm, there may be palpitations, weakness, and impaired reaction time (ACGIH, 1991).
- Rotogravure printers who had been exposed to an estimated 83 ppm of toluene for 1 to 36 years had altered neurologic signs, including parameters of electrocardiographic R-R intervals reflecting parasympathetic function, compared with age matched controls; nerve conduction velocities were unaltered. These results indicate that toluene exerts its chronic neurotoxic effects primarily at the CNS level (Murata et al, 1993).
- Decreased wave amplitudes in brainstem auditory evoked potentials were seen in 49 workers exposed to low levels of toluene for an average of 20.3 years (Vrca et al, 1996). Spray paint abusers had structural changes in the brain, determined by spin-echo magnetic resonance (Xiong et al, 1993).
- Several studies have reported loss of color vision in workers chronically exposed to high levels of toluene (Zavalic et al, 1998a) 1998b).
- Toluene has been shown to be ototoxic in chronic occupational exposures (Morata et al, 1994). Forty-nine percent of a group of Brazilian workers exposed to toluene, ethyl acetate, and ethanol experienced hearing loss; the strongest correlations were seen with markers of toluene exposure (Morata et al, 1997).
- Workers exposed to more than 100 ppm toluene for at least 10 years obtained worse scores on tests of visuospatial function, number learning and word recognition, and reported more symptoms of poor concentration, reduced memory and fatigue than did workers with lower exposures (Eller et al, 1999).
- The neurological effects of chronic exposure to high levels of toluene gradually progress to an irreversible state (ACGIH, 1992). Besides effects on behavior and intelligence, degeneration of the optic nerve and nerve deafness have also been reported in glue sniffers (Ehyai & Freemon, 1983). Chronic organic brain dysfunction, with cerebral and cerebellar atrophy, also occurs in chronic inhalational abuse (Hathaway et al, 1996).
- Toluene has produced similar neurological effects in experimental animals, including slow learning (Miyake, 1983) and hearing loss (Pryor, 1984; Pryor, 1984b; Rebert, 1983).
- Other effects of chronic exposure to toluene include SUDDEN DEATH in glue sniffers, apparently due to a decrease in the myocardial threshold to the arrhythmogenic effects of epinephrine (adrenaline), enlargement of the liver, and defatting dermatitis from repeated contact with the skin (Clayton & Clayton, 1994; HSDB , 2001). Metabolic acidosis and kidney damage have been reported in cases of prolonged glue sniffing (Kamijima et al, 1994).
- Several reviewers have stated that toluene does not have the hematopoietic effects of its parent compound, benzene. However, many older reports of effects on the blood from chronic exposure to toluene exist (Hathaway et al, 1996; Clayton & Clayton, 1994).
There have been cases of aplastic anemia from toluene in industrial exposures and also in glue sniffers (ACGIH, 1992). Increased coagulation time and reduced clotting factors have also been found, indicators of damage to the bone marrow (Clayton & Clayton, 1994). Most reviewers interpret these effects on the blood as being due to low levels of benzene as a contaminant of toluene. The question of whether or not pure toluene is myelosuppressive remains open (ACGIH, 1991).
-FIRST AID
FIRST AID AND PREHOSPITAL TREATMENT
May induce emesis and increase the risk of aspiration. Charcoal should only be considered after recent, substantial ingestion. Endotracheal intubation should be performed first in any patient with decreased mental status. PREHOSPITAL ACTIVATED CHARCOAL ADMINISTRATION Consider prehospital administration of activated charcoal as an aqueous slurry in patients with a potentially toxic ingestion who are awake and able to protect their airway. Activated charcoal is most effective when administered within one hour of ingestion. Administration in the prehospital setting has the potential to significantly decrease the time from toxin ingestion to activated charcoal administration, although it has not been shown to affect outcome (Alaspaa et al, 2005; Thakore & Murphy, 2002; Spiller & Rogers, 2002). In patients who are at risk for the abrupt onset of seizures or mental status depression, activated charcoal should not be administered in the prehospital setting, due to the risk of aspiration in the event of spontaneous emesis. The addition of flavoring agents (cola drinks, chocolate milk, cherry syrup) to activated charcoal improves the palatability for children and may facilitate successful administration (Guenther Skokan et al, 2001; Dagnone et al, 2002).
CHARCOAL DOSE Use a minimum of 240 milliliters of water per 30 grams charcoal (FDA, 1985). Optimum dose not established; usual dose is 25 to 100 grams in adults and adolescents; 25 to 50 grams in children aged 1 to 12 years (or 0.5 to 1 gram/kilogram body weight) ; and 0.5 to 1 gram/kilogram in infants up to 1 year old (Chyka et al, 2005). Routine use of a cathartic with activated charcoal is NOT recommended as there is no evidence that cathartics reduce drug absorption and cathartics are known to cause adverse effects such as nausea, vomiting, abdominal cramps, electrolyte imbalances and occasionally hypotension (None Listed, 2004).
ADVERSE EFFECTS/CONTRAINDICATIONS Complications: emesis, aspiration (Chyka et al, 2005). Aspiration may be complicated by acute respiratory failure, ARDS, bronchiolitis obliterans or chronic lung disease (Golej et al, 2001; Graff et al, 2002; Pollack et al, 1981; Harris & Filandrinos, 1993; Elliot et al, 1989; Rau et al, 1988; Golej et al, 2001; Graff et al, 2002). Refer to the ACTIVATED CHARCOAL/TREATMENT management for further information. Contraindications: unprotected airway (increases risk/severity of aspiration) , nonfunctioning gastrointestinal tract, uncontrolled vomiting, and ingestion of most hydrocarbons (Chyka et al, 2005).
-MEDICAL TREATMENT
LIFE SUPPORT
- Support respiratory and cardiovascular function.
SUMMARY
- FIRST AID - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 130 (ERG, 2004)
Move victim to fresh air. Call 911 or emergency medical service. Give artificial respiration if victim is not breathing. Administer oxygen if breathing is difficult. Remove and isolate contaminated clothing and shoes. In case of contact with substance, immediately flush skin or eyes with running water for at least 20 minutes. Wash skin with soap and water. Keep victim warm and quiet. In case of burns, immediately cool affected skin for as long as possible with cold water. Do not remove clothing if adhering to skin. Effects of exposure (inhalation, ingestion or skin contact) to substance may be delayed. Ensure that medical personnel are aware of the material(s) involved and take precautions to protect themselves.
FIRST AID EYE EXPOSURE: Immediately wash the eyes with large amounts of water, occasionally lifting the lower and upper lids. Get medical attention immediately. Primary eye protection (spectacles or goggles), as defined by the Occupational Safety and Health Administration (OSHA), should be used when working with this chemical. Face shields should only be worn over primary eye protection. DERMAL EXPOSURE: Promptly wash the contaminated skin with soap and water. If this chemical penetrates the clothing, promptly remove the clothing and wash the skin with soap and water. Get medical attention promptly. INHALATION EXPOSURE: Move the exposed person to fresh air at once. If breathing has stopped, perform artificial respiration. Keep the affected person warm and at rest. Get medical attention as soon as possible. ORAL EXPOSURE: If this chemical has been swallowed, get medical attention immediately. TARGET ORGANS: Eyes, skin, respiratory system, central nervous system, liver and kidneys (National Institute for Occupational Safety and Health, 2007; Chemsoft(R) , 2000).
INHALATION EXPOSURE INHALATION: Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with an inhaled beta2-adrenergic agonist. Consider systemic corticosteroids in patients with significant bronchospasm.
DERMAL EXPOSURE EYE EXPOSURE DECONTAMINATION: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, the patient should be seen in a healthcare facility.
ORAL EXPOSURE EMESIS is NOT indicated after ingestion because of the possibility of aspiration. Activated charcoal is not recommended in the prehospital setting, because of the substantial risk for emesis and aspiration. Monitor fluid and electrolyte status carefully. Correct hypokalemia and acidosis with potassium and bicarbonate. Caution - Hypocalcemia may ensue following fluid and electrolyte replenishment. Monitor patient for respiratory distress. Monitor EKG and vital signs regularly.
-RANGE OF TOXICITY
MINIMUM LETHAL EXPOSURE
ADULT Ingestion of approximately 60 mL of toluene produced death within 30 minutes in a 51-year-old male (Ameno et al, 1989). Following an occupational exposure, a painter died after an acute inhalational paint thinner intoxication. The concentration of toluene measured in the blood at the time of death was 30.2 mg/L. Based on this case, in combination with previous toxicokinetic research, a fatal concentration of toluene was estimated to be from 1800 to 2000 ppm for a 1-hour exposure (Hobara et al, 2000).
MAXIMUM TOLERATED EXPOSURE
Workers repeatedly exposed at 200 to 500 ppm have reported loss of coordination, memory loss, loss of appetite, and reversible disorders of the optic nerves. Concentrations above this up to 1500 ppm have caused similar, but more severe effects. Exposure to air concentrations of toluene from 10,000 to 30,000 ppm may cause mental confusion, inebriation, and unconsciousness with a few minutes (Baselt, 2000a). 200 to 500 ppm may cause headache, nausea, and giddiness (OHM/TADS , 2002).
- SYMPTOMS BASED ON EXPOSURE
SYMPTOMS at 200 parts per million: Mild upper respiratory tract irritation (Bingham et al, 2001). SYMPTOMS at 400 parts per million: Mild eye irritation, lacrimation, and hilarity (Bingham et al, 2001). SYMPTOMS at 600 parts per million: Lassitude, hilarity, and slight nausea (Bingham et al, 2001). SYMPTOMS at 600 TO 800 parts per million (ppm): Some subjects exposed to toluene concentrations of 600 to 800 ppm for 3 hours developed severe fatigue, extreme nausea, confusion, and a staggering gait (Finkel, 1983). SYMPTOMS AT 800 parts per million: Rapid dermal, mucosal, and eye irritation, nasal mucous secretion, metallic taste in the mouth, drowsiness, and impaired balance (Bingham et al, 2001). CASE REPORT: A 14-year-old female was brought to the emergency department (ED) because of confusion, episodes of laughing and crying, and disorientation to time and place. She admitted to sniffing contact glue several times daily for the past 5 days. Four hours after ED admission, urine hippuric acid was found to be 93.9 g/g creatinine, indicative of massive toluene exposure (Raikhlin-Eisenkraft et al, 2001). NOAEL/CHRONIC: In one study, employees from 14 magazine rotary printing plants (n=192) were examined to determine the cognitive effects of long-term exposure to toluene (below 50 parts per million (ppm)). The authors found no evidence of impaired neuropsychological performance due to long-term toluene exposure below 50 ppm (Seeber et al, 2004).
- Carcinogenicity Ratings for CAS108-88-3 :
ACGIH (American Conference of Governmental Industrial Hygienists, 2010): A4 ; Listed as: Toluene EPA (U.S. Environmental Protection Agency, 2011): Inadequate evidence to assess carcinogenic potential ; Listed as: Toluene IARC (International Agency for Research on Cancer (IARC), 2016; International Agency for Research on Cancer, 2015; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010a; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2008; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006; IARC, 2004): 3 ; Listed as: Toluene 3 : The agent (mixture or exposure circumstance) is not classifiable as to its carcinogenicity to humans. This category is used most commonly for agents, mixtures and exposure circumstances for which the evidence of carcinogenicity is inadequate in humans and inadequate or limited in experimental animals. Exceptionally, agents (mixtures) for which the evidence of carcinogenicity is inadequate in humans but sufficient in experimental animals may be placed in this category when there is strong evidence that the mechanism of carcinogenicity in experimental animals does not operate in humans. Agents, mixtures and exposure circumstances that do not fall into any other group are also placed in this category.
NIOSH (National Institute for Occupational Safety and Health, 2007): Not Listed ; Listed as: Toluene MAK (DFG, 2002): Not Listed NTP (U.S. Department of Health and Human Services, Public Health Service, National Toxicology Project ): Not Listed
TOXICITY AND RISK ASSESSMENT VALUES
- EPA Risk Assessment Values for CAS108-88-3 (U.S. Environmental Protection Agency, 2011):
Oral: Slope Factor: RfD: 8x10(-2) mg/kg-day
Inhalation: Drinking Water:
References: Bingham et al, 2001 Lewis, 2000 OHM/TADS, 2002 RTECS, 2002 NOEL- (ORAL)MOUSE: NOEL- (INHALATION)RAT: NOEL- (ORAL)RAT: Female, 118 mg/kg/day for 193D (Bingham et al, 2001) Female, 353 mg/kg/day for 193D (Bingham et al, 2001) Female, 590 mg/kg/day for 193D (Bingham et al, 2001)
References: Bingham et al, 2001 Lewis, 2000 OHM/TADS, 2002 RTECS, 2002 LC50- (INHALATION)MOUSE: LC50- (INHALATION)RAT: 49 g/m(3) for 4H 4000 ppm (15.2 mg/L) for 4H (Bingham et al, 2001) 8000 ppm (30.4 mg/L) for 4H (Bingham et al, 2001; OHM/TADS, 2002) 8800 ppm (35.0 mg/L) for 4H (Bingham et al, 2001)
LCLo- (INHALATION)GUINEA_PIG: LCLo- (INHALATION)RABBIT: LCLo- (INHALATION)RAT: LD50- (INTRAPERITONEAL)GUINEA_PIG: LD50- (INTRAPERITONEAL)MOUSE: 59 mg/kg 640 mg/kg (Lewis, 2000)
LD50- (SUBCUTANEOUS)MOUSE: LD50- (SKIN)RABBIT: 12,124 mg/kg (Lewis, 2000) 14 g/kg (Bingham et al, 2001) 12,211 mg/kg for 14D (Bingham et al, 2001) 14,100 mcL/kg
LD50- (INTRAPERITONEAL)RAT: 800 mg/kg (OHM/TADS, 2002) 1332 mg/kg 1640 mg/kg (OHM/TADS, 2002)
LD50- (INTRAVENOUS)RAT: LD50- (ORAL)RAT: 636 mg/kg 5000 mg/kg (Lewis, 2000) 5850 mg/kg (OHM/TADS, 2002) 7530 mg/kg for 14D (OHM/TADS, 2002) 7.0 g/kg (Bingham et al, 2001; OHM/TADS, 2002) 7.4 g/kg (Bingham et al, 2001) 7.53 g/kg (Bingham et al, 2001) 14D-old, 3.0 mL/kg (Bingham et al, 2001)
LD50- (SUBCUTANEOUS)RAT: LDLo- (ORAL)HUMAN: LDLo- (INTRAVENOUS)RABBIT: LDLo- (INTRAPERITONEAL)RAT: TCLo- (INHALATION)HAMSTER: TCLo- (INHALATION)HUMAN: TCLo- (INHALATION)MOUSE: 1000 ppm for 6H/20D - intermittent -- somnolence (general depressed activity); changes in erythrocyte and leukocyte count 1250 ppm for 6H/14W - intermittent -- changes in liver weight; death 12,000 ppm for 10M/8W - intermittent -- changes in liver and bladder weights; weight loss or decreased weight gain Female, 500 mg/m(3) for 24H at 6-13D of pregnancy -- fetotoxicity Female, 200 ppm for 7H at 7-16D of pregnancy -- developmental abnormalities of the urogenital system Female, 400 ppm for 7H at 7-16D of pregnancy -- musculoskeletal developmental abnormalities; biochemical and metabolic effects in newborn Female, 1000 ppm for 6H at 2-17D of pregnancy --musculoskeletal system developmental abnormalities
TCLo- (INHALATION)RABBIT: 50 mg/m(3) for 4H/26W - intermittent -- muscle contraction or spasticity Female, 1 g/m(3) for 24H at 7-20D of pregnancy -- abortion Female, 100 ppm for 6H at 6-18D of pregnancy -- cardiovascular system developmental abnormalities
TCLo- (INHALATION)RAT: 300 mg/m(3) for 5H/21D - intermittent -- changes in sense organs and special senses 300 ppm for 6H/2Y - intermittent -- changes in blood, including pigmented or nucleated red blood cells; weight loss or decreased weight gain 320 ppm for 24H/30D - continuous -- changes in brain weight; weight loss or decreased weight gain; effects on lipids, including transport 1500 ppm for 6H/26W - intermittent -- degenerative changes in the brain and its coverings; kidney, ureter and bladder changes; dopamine in striatum 1600 ppm for 20H/7D - intermittent -- kidney, ureter and bladder changes; weight loss or decreased weight gain; death 2200 ppm for 8H/23W - intermittent -- ataxia; musculoskeletal changes; weight loss or decreased weight gain 2500 ppm for 6.5H/15W - intermittent -- changes in heart, liver and bladder weights 12,000 ppm for 10M/8W - intermittent -- changes in bladder weight; weight loss or decreased weight gain; effects on transaminases Female, 800 mg/m(3) for 6H at 14-20D of pregnancy -- fetotoxicity; behavioral effects in newborn Female, 1000 mg/m(3) for 24H at 7-14D of pregnancy -- developmental abnormalities of the musculoskeletal system Female, 1500 mg/m(3) for 24H at 1-8D of pregnancy --fetotoxicity; musculoskeletal system developmental abnormalities Female, 1200 ppm for 6H at 9-12D of pregnancy -- delayed effects in newborn Female, 2000 ppm for 6H at 7-17D of pregnancy -- maternal effects; physical effects in newborn Female, 6000 ppm for 2H/5W - intermittent
TDLo- (ORAL)MOUSE: 2940 mg/kg for 4W - continuous -- changes in liver and thymus weights; decreased immune response 8400 mg/kg for 14D - intermittent -- changes in leukocyte and other blood cell count 227 g/kg for 13W - intermittent -- changes in brain, liver and bladder weights Female, 9 g/kg at 6-15D of pregnancy -- fetal death Female, 15 g/kg at 6-15D of pregnancy -- fetotoxicity Female, 30 g/kg at 6-15D of pregnancy -- craniofacial developmental abnormalities
TDLo- (INTRAPERITONEAL)RAT: TDLo- (ORAL)RAT: 27,645 mg/kg for 3W - intermittent -- proteinuria and other changes in urine composition 42,380 mg/kg for 49D - intermittent -- change in cochlear structure or function; weight loss or decreased weight gain 162 g/kg for 13W - intermittent -- changes in brain, liver and bladder weights Female, 16 mL/kg at 6-21D of pregnancy -- physical effects in newborn Female, 7280 mg/kg at 6-19D of pregnancy -- fetotoxicity Female, 9100 mg/kg at 6-19D of pregnancy -- change in newborn growth; biochemical and metabolic effects in newborn
TDLo- (SUBCUTANEOUS)RAT:
CALCULATIONS
1 ppm = 3.77 mg/m(3) (at 1 atm) (Bingham et al, 2001) 1 mg/m(3) = 0.26 ppm (Verschueren, 2001) 1 ppm = 3.83 mg/m(3) (Verschueren, 2001) 1 ppm = 3.76 mg/m(3) (HSDB , 2002) 1 mg/L = 226 ppm (HSDB , 2002)
-STANDARDS AND LABELS
WORKPLACE STANDARDS
- ACGIH TLV Values for CAS108-88-3 (American Conference of Governmental Industrial Hygienists, 2010):
Editor's Note: The listed values are recommendations or guidelines developed by ACGIH(R) to assist in the control of health hazards. They should only be used, interpreted and applied by individuals trained in industrial hygiene. Before applying these values, it is imperative to read the introduction to each section in the current TLVs(R) and BEI(R) Book and become familiar with the constraints and limitations to their use. Always consult the Documentation of the TLVs(R) and BEIs(R) before applying these recommendations and guidelines.
- AIHA WEEL Values for CAS108-88-3 (AIHA, 2006):
- NIOSH REL and IDLH Values for CAS108-88-3 (National Institute for Occupational Safety and Health, 2007):
Listed as: Toluene REL: TWA: 100 ppm (375 mg/m(3)) STEL: 150 ppm (560 mg/m(3)) Ceiling: Carcinogen Listing: (Not Listed) Not Listed Skin Designation: Not Listed Note(s):
IDLH: IDLH: 500 ppm Note(s): Not Listed
- OSHA PEL Values for CAS108-88-3 (U.S. Occupational Safety, and Health Administration (OSHA), 2010):
- OSHA List of Highly Hazardous Chemicals, Toxics, and Reactives for CAS108-88-3 (U.S. Occupational Safety and Health Administration, 2010):
ENVIRONMENTAL STANDARDS
- EPA CERCLA, Hazardous Substances and Reportable Quantities for CAS108-88-3 (U.S. Environmental Protection Agency, 2010):
Listed as: Toluene Final Reportable Quantity, in pounds (kilograms): Additional Information: The following spent non-halogenated solvents and the still bottoms from the recovery of these solvents. (F005) Listed as: Toluene Final Reportable Quantity, in pounds (kilograms): Additional Information: Listed as: Benzene, methyl- Final Reportable Quantity, in pounds (kilograms): Additional Information:
- EPA CERCLA, Hazardous Substances and Reportable Quantities, Radionuclides for CAS108-88-3 (U.S. Environmental Protection Agency, 2010):
- EPA RCRA Hazardous Waste Number for CAS108-88-3 (U.S. Environmental Protection Agency, 2010b):
Listed as: Benzene, methyl- P or U series number: U220 Footnote: Listed as: Toluene P or U series number: U220 Footnote: Editor's Note: The D, F, and K series waste numbers and Appendix VIII to Part 261 -- Hazardous Constituents were not included. Please refer to 40 CFR Part 261.
- EPA SARA Title III, Extremely Hazardous Substance List for CAS108-88-3 (U.S. Environmental Protection Agency, 2010):
- EPA SARA Title III, Community Right-to-Know for CAS108-88-3 (40 CFR 372.65, 2006; 40 CFR 372.28, 2006):
- DOT List of Marine Pollutants for CAS108-88-3 (49 CFR 172.101 - App. B, 2005):
- EPA TSCA Inventory for CAS108-88-3 (EPA, 2005):
SHIPPING REGULATIONS
- DOT -- Table of Hazardous Materials and Special Provisions for UN/NA Number 1294 (49 CFR 172.101, 2005):
- ICAO International Shipping Name for UN1294 (ICAO, 2002):
LABELS
- NFPA Hazard Ratings for CAS108-88-3 (NFPA, 2002):
Listed as: Toluene Hazard Ratings: Health Rating (Blue): 2 Flammability Rating (Red): 3 (3) Flammable. Liquids and solids that can be ignited under almost all ambient temperature conditions. Including liquids with a flash point below 73 degrees F and a boiling point above 100 degrees F, solid materials which form coarse dusts that burn rapidly without becoming explosive, materials which burn rapidly by reason of self-contained oxygen (ie, organic peroxides), and materials which ignite spontaneously when exposed to air.
Instability Rating (Yellow): 0 Oxidizer/Water-Reactive Designation: Not Listed
-HANDLING AND STORAGE
SUMMARY
Toluene is a central nervous system depressant and a severe eye and skin irritant. It is toxic by inhalation, ingestion and/or dermal contact. Exposure to toluene vapor and liquid should be avoided (AAR, 2000; Bingham et al, 2001; CHRIS , 2002; NIOSH, 2002) NTP, 2001). Adequate protective clothing and equipment, including respiratory protection, should be worn at all times when working with or near toluene (AAR, 2000; CHRIS , 2002; NIOSH, 2002).
HANDLING
- Protect containers against physical damage (ITI, 1995; OHM/TADS , 2002; Sittig, 1991).
- Avoid skin contact with toluene. Wear eye protection, self-contained breathing apparatus and chemical protective gloves (AAR, 2000; ITI, 1995). Contact lenses should not be worn (HSDB , 2002).
Do not handle broken packages unless wearing appropriate personal protective equipment (AAR, 2000; OHM/TADS , 2002). If toluene contacts the skin, affected areas should be flooded with water and any contaminated clothing removed and isolated. Skin should be gently washed with a soap and water solution (AAR, 2000) NTP, 2001). If toluene contacts the eyes, first remove contact lenses if present, and flush the eyes with water or a normal saline solution for 20 to 30 minutes (NTP, 2001).
- When transferring 5 gallons or more of toluene, metal containers should be grounded and bonded. Use only non-sparking tools and equipment (OHM/TADS , 2002; Sittig, 1991).
- Use proper control in nitration of toluene with mixed acids to avoid runaway or explosive reactions (Urben, 1999).
- Toluene-containing products should be used in well-ventilated areas (ATSDR, 1994).
STORAGE
The usual shipping containers are glass bottles, cans, drums and tanks on trucks, rail cars and barges (NFPA, 1997). Toluene will attack some plastics, rubber and coatings (Pohanish & Greene, 1997). Containers should be tightly sealed to prevent evaporation (ATSDR, 1994).
- ROOM/CABINET RECOMMENDATIONS
Outside or detached storage is preferred; inside storage should be in a standard flammable liquids storage warehouse, room, or cabinet (ITI, 1995; NFPA, 1997; OHM/TADS , 2002). Sources of ignition (such as smoking or open flames) are prohibited where toluene is stored or handled (NTP, 2001; (Sittig, 1991). Toluene should be stored in an explosion-proof, refrigerated area with an inert atmosphere. It should be kept away from moisture (CHRIS , 2002) NTP, 2001). Rooms used to store toluene should be equipped with drench-type showers and eye-wash fountains (HSDB , 2002). Venting should be open (flame arrester) or pressure-vacuum (CHRIS , 2002).
Separate from oxidizing materials (such as chlorine, bromine and fluorine) to avoid violent reactions (NFPA, 1997; Sittig, 1991). Toluene can react vigorously with oxidizing materials; toluene vapor is explosive when exposed to heat or flame (Lewis, 2000; Pohanish & Greene, 1997). Toluene reacts explosively with the following compounds: 1,3-dichloro-5,5-dimethyl-2,4-imidazolididione, dinitrogen tetraoxide, concentrated nitric acid, sulfuric acid plus plus nitric acid, nitrogen tetraoxide, trifluoroborane, uranium trifluoride, sulfur dichloride. Toluene forms an explosive mixture with tetranitromethane (Lewis, 2000). When bromine trifluoride (BrF3) is a frozen solid at minus 80 degrees C, it reacts violently with toluene (Urben, 1999). A mild steel storage tank containing sulfur dichloride (Cl2S) ruptured by overpressurization after toluene was added. This was caused by the exothermic reaction between toluene and sulfur dichloride, which was catalyzed by iron or iron (III) chloride (Urben, 1999). Interaction between toluene and uranium hexafluoride (UF6) is very vigorous (ITI, 1995; Urben, 1999). A mixture of toluene and dinitrogen tetraoxide (N2O4) exploded, possibly due to unsaturated impurities (Urben, 1999). Tetranitromethane (CN4O8) mixed with hydrocarbons in approximately stoichiometric proportions produces a sensitive, highly explosive mixture. Ten grams of this type of mixture containing excess toluene exploded causing 10 deaths and 20 severe injuries (Urben, 1999).
There is a possible explosion hazard of toluene plus allyl chloride in the presence of dichloroethyl aluminum or ethylaluminum sesquichloride (ITI, 1995). Toluene will attack some plastics, rubber and coatings (Pohanish & Greene, 1997).
-PERSONAL PROTECTION
SUMMARY
- RECOMMENDED PROTECTIVE CLOTHING - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 130 (ERG, 2004)
- Adequate personal protective clothing and equipment should be worn to prevent eye and skin contact with toluene (AAR, 2000; NIOSH, 2002).
- Avoid breathing toluene vapors; keep upwind. Avoid skin contact with toluene; wear solvent resistant gloves and clothing. Wash away any toluene that contacts the body with copious amounts of water or soap and water (AAR, 2000; NIOSH, 2002; Sittig, 1991).
- Wear full chemical protective clothing and equipment, including positive pressure self-contained breathing apparatus, when responding to a toluene spill (NFPA, 1997).
- Any contaminated clothing should be removed and placed in a vapor-tight bag or container for later disposal (NTP, 2001).
EYE/FACE PROTECTION
- When working with liquid toluene, wear splash-proof chemical goggles and a face shield unless full facepiece respiratory protection is worn (OHM/TADS , 2002; Sittig, 1991).
- Contact lenses should not be worn when working with this chemical (HSDB , 2002).
RESPIRATORY PROTECTION
- In areas where toluene is used, workers should wear a NIOSH-approved half-face respirator with an organic vapor/acid gas cartridge with a dust/mist filter or other NIOSH-approved self-contained breathing apparatus (NTP, 2001; (OHM/TADS , 2002).
PROTECTIVE CLOTHING
- CHEMICAL PROTECTIVE CLOTHING. Search results for CAS 108-88-3.
-PHYSICAL HAZARDS
FIRE HAZARD
POTENTIAL FIRE OR EXPLOSION HAZARDS - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 130 (ERG, 2004) HIGHLY FLAMMABLE: Will be easily ignited by heat, sparks or flames. Vapors may form explosive mixtures with air. Vapors may travel to source of ignition and flash back. Most vapors are heavier than air. They will spread along ground and collect in low or confined areas (sewers, basements, tanks). Vapor explosion hazard indoors, outdoors or in sewers. Those substances designated with a "P" may polymerize explosively when heated or involved in a fire. Runoff to sewer may create fire or explosion hazard. Containers may explode when heated. Many liquids are lighter than water.
Toluene is a flammable liquid and is a very dangerous fire hazard when exposed to heat, flame, or oxidizers. Its vapors are heavier than air and may travel to a source of ignition and flash back. Liquid toluene floats on water and may travel to a source of ignition and spread fire. Toluene may accumulate static electricity (CHRIS , 2002; Lewis, 2000; NFPA, 1997). If toluene is not on fire, keep sparks, flames, and other sources of ignition away from it. Keep it out of water sources and sewers; build dikes to contain flow as necessary. Use water spray to knock down vapors (AAR, 2000). If toluene is on fire, do not extinguish the fire unless flow can be stopped or safely confined. Use water in flooding quantities as fog; solid streams of water may spread the fire. Cool all affected containers with flooding quantities of water; apply water from as far a distance as possible (AAR, 2000).
- FLAMMABILITY CLASSIFICATION
- NFPA Flammability Rating for CAS108-88-3 (NFPA, 2002):
Listed as: Toluene Flammability Rating: 3 (3) Flammable. Liquids and solids that can be ignited under almost all ambient temperature conditions. Including liquids with a flash point below 73 degrees F and a boiling point above 100 degrees F, solid materials which form coarse dusts that burn rapidly without becoming explosive, materials which burn rapidly by reason of self-contained oxygen (ie, organic peroxides), and materials which ignite spontaneously when exposed to air.
- INITIATING OR CONTRIBUTING PROPERTIES
Toluene has a flash point of 40 degrees F (4 degrees C) (Lewis, 2000; NIOSH, 2002; NFPA, 1997). Toluene may accumulate static electricity (NFPA, 1997).
- FIRE CONTROL/EXTINGUISHING AGENTS
- FIRE PRECAUTIONS - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 130 (ERG, 2004)
- SMALL FIRE PRECAUTIONS - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 130 (ERG, 2004)
- LARGE FIRE PRECAUTIONS - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 130 (ERG, 2004)
Water spray, fog or regular foam. Do not use straight streams. Move containers from fire area if you can do it without risk.
- TANK OR CAR/TRAILER LOAD FIRE PRECAUTIONS - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 130 (ERG, 2004)
Fight fire from maximum distance or use unmanned hose holders or monitor nozzles. Cool containers with flooding quantities of water until well after fire is out. Withdraw immediately in case of rising sound from venting safety devices or discoloration of tank. ALWAYS stay away from tanks engulfed in fire. For massive fire, use unmanned hose holders or monitor nozzles; if this is impossible, withdraw from area and let fire burn.
- NFPA Extinguishing Methods for CAS108-88-3 (NFPA, 2002):
- Approach a fire from upwind; use dry chemical, foam, or carbon dioxide. Use water spray to keep containers cool (AAR, 2000; Lewis, 2000; NFPA, 1997).
- Water may be ineffective in extinguishing a fire involving toluene (CHRIS , 2002).
EXPLOSION HAZARD
- Toluene can react vigorously with oxidizing materials; toluene vapor is explosive when exposed to heat or flame. It may form explosive mixtures with air (Lewis, 2000; Pohanish & Greene, 1997).
- Toluene vapor may explode if it is exposed to heat or flame in an enclosed area (CHRIS , 2002; Lewis, 2000).
- Toluene reacts explosively with the following compounds: 1,3-dichloro-5,5-dimethyl-2,4-imidazolididione, dinitrogen tetraoxide, concentrated nitric acid, sulfuric acid plus nitric acid, nitrogen tetroxide, trifluoroborane, uranium trifluoride, sulfur dichloride (Lewis, 2000).
- Toluene forms an explosive mixture with tetranitromethane (Lewis, 2000).
- Toluene plus allyl chloride in the presence of dichloroethyl aluminum or ethylaluminum sesquichloride is a possible explosion hazard (ITI, 1995).
DUST/VAPOR HAZARD
- Toluene vapors are heavier than air and may travel to a sources of ignition and flash back (NFPA, 1997).
- When heated to decomposition, toluene emits acrid smoke and irritating fumes; approach fire from upwind to avoid hazardous vapors and toxic decomposition products (Lewis, 2000; NFPA, 1997).
- Toluene vapor may form explosive mixtures with air (Pohanish & Greene, 1997).
- Toluene vapors cause acute CNS depression, with noticeable toxic effects starting at exposure levels of approximately 50 parts per million (ppm). Exposure to 100 to 200 ppm has been associated with headache and mild, transient irritation of the respiratory tract (ACGIH, 1991). Exposure to 200 to 500 ppm for several weeks caused headache, mild eye irritation, nausea, lassitude, lacrimation, impairment of coordination, hilarity, and memory loss. Concentrations of 500 to 1000 ppm may result in similar but more severe effects, as well as nasal discharge, drowsiness, ataxia, and dizziness. Exposure to 10,000 to 30,000 ppm of toluene may cause mental confusion and drunkenness, resulting in unconsciousness within a few minutes (ACGIH, 1991; Baselt, 2000).
REACTIVITY HAZARD
- Toluene can react vigorously with oxidizing materials; toluene vapor is explosive when exposed to heat or flame (Lewis, 2000; Pohanish & Greene, 1997).
- Toluene reacts explosively with the following compounds: 1,3-dichloro-5,5-dimethyl-2,4-imidazolididione, dinitrogen tetraoxide, concentrated nitric acid, sulfuric acid plus plus nitric acid, nitrogen tetroxide, trifluoroborane, uranium trifluoride, sulfur dichloride. Toluene forms an explosive mixture with tetranitromethane (Lewis, 2000).
When bromine trifluoride (BrF3) is a frozen solid at minus 80 degrees C, it reacts violently with toluene (Urben, 1999). A mild steel storage tank containing sulfur dichloride (Cl2S) ruptured by overpressurization after toluene was added. This was caused by the exothermic reaction between toluene and sulfur dichloride which was catalyzed by iron or iron (III) chloride (Urben, 1999). Interaction between toluene and uranium hexafluoride (UF6) is very vigorous (ITI, 1995; Urben, 1999). Use proper control in nitration of toluene with mixed acids to avoid runaway or explosive reactions (Urben, 1999). A mixture of toluene and dinitrogen tetraoxide (N2O4) exploded, possibly due to unsaturated impurities (Urben, 1999). Tetranitromethane (CN4O8) mixed with hydrocarbons in approximately stoichiometric proportions produces a sensitive, highly explosive mixture. Ten grams of this type of mixture containing excess toluene exploded causing 10 deaths and 20 severe injuries (Urben, 1999).
- There is a possible explosion hazard of toluene plus allyl chloride in the presence of dichloroethyl aluminum or ethylaluminum sesquichloride (ITI, 1995).
- Toluene will attack some plastics, rubber, and coatings (Pohanish & Greene, 1997).
EVACUATION PROCEDURES
- Editor's Note: This material is not listed in the Table of Initial Isolation and Protective Action Distances.
- LARGE SPILL - PUBLIC SAFETY EVACUATION DISTANCES - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 130 (ERG, 2004)
- FIRE - PUBLIC SAFETY EVACUATION DISTANCES - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 130 (ERG, 2004)
If tank, rail car or tank truck is involved in a fire, ISOLATE for 800 meters (1/2 mile) in all directions; also, consider initial evacuation for 800 meters (1/2 mile) in all directions.
- PUBLIC SAFETY MEASURES - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 130 (ERG, 2004)
CALL Emergency Response Telephone Number on Shipping Paper first. If Shipping Paper not available or no answer, refer to appropriate telephone number: MEXICO: SETIQ: 01-800-00-214-00 in the Mexican Republic; For calls originating in Mexico City and the Metropolitan Area: 5559-1588; For calls originating elsewhere, call: 011-52-555-559-1588.
CENACOM: 01-800-00-413-00 in the Mexican Republic; For calls originating in Mexico City and the Metropolitan Area: 5550-1496, 5550-1552, 5550-1485, or 5550-4885; For calls originating elsewhere, call: 011-52-555-550-1496, or 011-52-555-550-1552; 011-52-555-550-1485, or 011-52-555-550-4885.
ARGENTINA: CIQUIME: 0-800-222-2933 in the Republic of Argentina; For calls originating elsewhere, call: +54-11-4613-1100.
BRAZIL: PRÓ-QUÍMICA: 0-800-118270 (Toll-free in Brazil); For calls originating elsewhere, call: +55-11-232-1144 (Collect calls are accepted).
COLUMBIA: CISPROQUIM: 01-800-091-6012 in Colombia; For calls originating in Bogotá, Colombia, call: 288-6012; For calls originating elsewhere, call: 011-57-1-288-6012.
CANADA: UNITED STATES:
For additional details see the section entitled "WHO TO CALL FOR ASSISTANCE" under the ERG Instructions. As an immediate precautionary measure, isolate spill or leak area for at least 50 meters (150 feet) in all directions. Keep unauthorized personnel away. Stay upwind. Keep out of low areas. Ventilate closed spaces before entering.
- Avoid breathing toluene vapors. Keep upwind of contaminated areas (AAR, 2000).
- Consider evacuation from downwind areas; base risk assessment on amount of spilled toluene, location, and weather conditions (AAR, 1994).
- AIHA ERPG Values for CAS108-88-3 (AIHA, 2006):
Listed as Toluene ERPG-1 (units = ppm): 50 ERPG-2 (units = ppm): 300 ERPG-3 (units = ppm): 1000 Under Ballot, Review, or Consideration: Yes Definitions: ERPG-1: The ERPG-1 is the maximum airborne concentration below which it is believed nearly all individuals could be exposed for up to one hour without experiencing more than mild, transient adverse health effects or perceiving a clearly defined objectionable odor. ERPG-2: The ERPG-2 is the maximum airborne concentration below which it is believed nearly all individuals could be exposed for up to one hour without experiencing or developing irreversible or other serious health effects or symptoms that could impair an individual's ability to take protective action. ERPG-3: The ERPG-3 is the maximum airborne concentration below which it is believed nearly all individuals could be exposed for up to one hour without experiencing or developing life-threatening health effects.
- DOE TEEL Values for CAS108-88-3 (U.S. Department of Energy, Office of Emergency Management, 2010):
Listed as Toluene TEEL-0 (units = ppm): 20 TEEL-1 (units = ppm): 200 TEEL-2 (units = ppm): 1200 TEEL-3 (units = ppm): 4500 Definitions: TEEL-0: The threshold concentration below which most people will experience no adverse health effects. TEEL-1: The airborne concentration (expressed as ppm [parts per million] or mg/m(3) [milligrams per cubic meter]) of a substance above which it is predicted that the general population, including susceptible individuals, could experience notable discomfort, irritation, or certain asymptomatic, nonsensory effects. However, these effects are not disabling and are transient and reversible upon cessation of exposure. TEEL-2: The airborne concentration (expressed as ppm or mg/m(3)) of a substance above which it is predicted that the general population, including susceptible individuals, could experience irreversible or other serious, long-lasting, adverse health effects or an impaired ability to escape. TEEL-3: The airborne concentration (expressed as ppm or mg/m(3)) of a substance above which it is predicted that the general population, including susceptible individuals, could experience life-threatening adverse health effects or death.
- AEGL Values for CAS108-88-3 (National Research Council, 2010; National Research Council, 2009; National Research Council, 2008; National Research Council, 2007; NRC, 2001; NRC, 2002; NRC, 2003; NRC, 2004; NRC, 2004; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2006; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2007; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2005; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2005; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2007; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2006; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2006; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2006; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2006; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2006; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2006; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2006; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2006; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2006; United States Environmental Protection Agency Office of Pollution Prevention and Toxics, 2006; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2006; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2007; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2007; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2007; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2007; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2007; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2009; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2009; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2009; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2009; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2009; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2009; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2009; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2009; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2009; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2009; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2009; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2009; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2009; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2008; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2007; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2006; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2006; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2006; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2007; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2007; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2007; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2007; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2007; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2005; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2005; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2005; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2005; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2005; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2005; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2005; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2005; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2007; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2005; National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances, 2006; 62 FR 58840, 1997; 65 FR 14186, 2000; 65 FR 39264, 2000; 65 FR 77866, 2000; 66 FR 21940, 2001; 67 FR 7164, 2002; 68 FR 42710, 2003; 69 FR 54144, 2004):
Listed as: Toluene Proposed Value: AEGL-1 10 min exposure: ppm: 260 ppm mg/m3: 980 mg/m(3)
30 min exposure: ppm: 120 ppm mg/m3: 450 mg/m(3)
1 hr exposure: ppm: 82 ppm mg/m3: 300 mg/m(3)
4 hr exposure: ppm: 41 ppm mg/m3: 150 mg/m(3)
8 hr exposure: ppm: 29 ppm mg/m3: 112 mg/m(3)
Definitions: AEGL-1 is the airborne concentration of a substance above which it is predicted that the general population, including susceptible individuals, could experience notable discomfort, irritation, or certain asymptomatic non-sensory effects. However, the effects are not disabling, are transient, and are reversible upon cessation of exposure.
Listed as: Toluene Proposed Value: AEGL-2 10 min exposure: ppm: 600 ppm mg/m3: 2260 mg/m(3)
30 min exposure: ppm: 270 ppm mg/m3: 1020 mg/m(3)
1 hr exposure: ppm: 190 ppm mg/m3: 710 mg/m(3)
4 hr exposure: ppm: 94 ppm mg/m3: 340 mg/m(3)
8 hr exposure: ppm: 67 ppm mg/m3: 260 mg/m(3)
Definitions: AEGL-2 is the airborne concentration of a substance above which it is predicted that the general population, including susceptible individuals, could experience irreversible or other serious, long-lasting adverse health effects or an impaired ability to escape.
Listed as: Toluene Proposed Value: AEGL-3 10 min exposure: ppm: 1600 ppm mg/m3: 6000 mg/m(3)
30 min exposure: ppm: 900 ppm mg/m3: 3380 mg/m(3)
1 hr exposure: ppm: 630 ppm mg/m3: 2360 mg/m(3)
4 hr exposure: ppm: 320 ppm mg/m3: 1200 mg/m(3)
8 hr exposure: ppm: 220 ppm mg/m3: 830 mg/m(3)
Definitions: AEGL-3 is the airborne concentration of a substance above which it is predicted that the general population, including susceptible individuals, could experience life-threatening health effects or death.
- NIOSH IDLH Values for CAS108-88-3 (National Institute for Occupational Safety and Health, 2007):
IDLH: 500 ppm Note(s): Not Listed
CONTAINMENT/WASTE TREATMENT OPTIONS
SPILL OR LEAK PRECAUTIONS - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 130 (ERG, 2004) ELIMINATE all ignition sources (no smoking, flares, sparks or flames in immediate area). All equipment used when handling the product must be grounded. Do not touch or walk through spilled material. Stop leak if you can do it without risk. Prevent entry into waterways, sewers, basements or confined areas. A vapor suppressing foam may be used to reduce vapors. Absorb or cover with dry earth, sand or other non-combustible material and transfer to containers. Use clean non-sparking tools to collect absorbed material.
RECOMMENDED PROTECTIVE CLOTHING - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 130 (ERG, 2004) Keep people away from the area of the spill. Shut off any ignition sources. Avoid contact with the liquid and vapor. Protect water intakes. Notify local health and safety personnel of the spill (CHRIS , 2002). Wear full chemical protective clothing and equipment, including positive pressure self-contained breathing apparatus, when responding to a toluene spill (NFPA, 1997). Any contaminated clothing should be removed and placed in a vapor-tight bag or container for later disposal (NTP, 2001).
In case of a toluene leak or spill, first eliminate all ignition sources, then stop or control the leak if it can be done without undue risk. Use water spray to cool and disperse vapors. Absorb spilled chemical in noncombustible material for proper disposal; control runoff and isolate discharged toluene for proper disposal (NFPA, 1997) NTP, 2001). If toluene is spilled on land, dig a pit, pond, lagoon, or similar holding area to contain liquid or solid material. Dike surface flow using soil, sand bags, foamed polyurethane or foamed concrete. Absorb bulk liquid with fly ash, cement powder or commercial sorbents. Apply a universal gelling agent to immobilize the spill. Apply appropriate foam to diminish vapor and fire hazard (AAR, 2000). If toluene is spilled on water, use natural barriers or oil spill control booms to the travel of the spilled material. Use surface active agent (eg, detergent, soaps, alcohols), if approved by EPA. Inject a universal gelling agent to solidify encircled spill and increase effectiveness of booms. If dissolved to 10 parts per million or greater concentration, apply activated carbon at 10 times the spilled amount. Remove trapped material with suction hoses; use mechanical dredges or lifts to remove immobilized masses of pollutants and precipitates (AAR, 2000). Solvent wash all contaminated surfaces with 60% to 70% ethanol, followed by washing with a soap and water solution (NTP, 2001).
A study was done to evaluate 3 systems for removing benzene, toluene, and xylene (BTX) from contaminated water. System 1 used granular activated charcoal (GAC), system 2 used GAC in conjunction with biological removal, and system 3 used microbial growth without adsorption. The results showed that system 2 gave the best combination of BTX removal and stable operation (Voice et al, 1992). Waste management activities associated with material disposition are unique to individual situations. Proper waste characterization and decisions regarding waste management should be coordinated with the appropriate local, state, or federal authorities to ensure compliance with all applicable rules and regulations.
Biofiltration, a process in which contaminated air is passed through a biologically active bed, was investigated for the ability to remove toluene from contaminated gas streams. A fungal vapor-phase bioreactor containing a strain of dimorphic black yeast, Exophiala lecanii-corni, was able to remove 270 g/m(3) toluene per hour. Removal efficiencies of greater than 95% were maintained through out the 175-day study; low moisture content, acidic biofilms, and nitrogen limitation did not adversely effect the removal efficiencies. Based upon these results, biofiltration may be an effective alternative to conventional technologies for treating high concentrations of toluene in waste gas streams (Woertz et al, 2001). Toluene is relatively biodegradable: a scenario in which an initial concentration of 2.22 mcg/L toluene, in the presence of other components of high-octane gasoline, was incubated at 13 degrees C with natural flora in the groundwater which resulted in 100% biodegradation after 192 hours (Verschueren, 2001). In-situ bioremediation of benzene, toluene, ethylbenzene, and the xylenes (BTEX) was conducted in a fuel-contaminated, oxygen-poor aquifer. Extracted groundwater was enriched with ammonium polyphosphate as nutrient and potassium nitrate as the electron acceptor. It was then piped to an infiltration gallery over the contaminated site. BTEX measurements declined by 78% in the most contaminated well and by nearly 99% in another well. Final data indicated that the BTEX was biodegraded in-situ in the nitrate-enriched aquifer under denitrifying conditions (Gersberg et al, 1995). Anaerobic growth of 4 pure cultures of denitrifying bacteria occurred with crude oil as the only source of organic substrate. After growth, chemical analysis indicated that toluene and ethylbenzene were selectively consumed from the oil; the pure compounds o-xylene and p-xylene were consumed to a lesser extent (Rabus & Widdel, 1996). In a static culture flask biodegradation test (original culture) using settled domestic wastewater as the microbial inoculum, 100% of the toluene was degraded in 7 days (Dragun, 1988).
Incineration is a suggested disposal method (Sittig, 1991). Toluene can be burned under controlled, regulated conditions (HSDB, 2004; OHM/TADS , 2002). Treat contaminated water by gravity separation of solids followed by skimming the surface. Pass contaminated water through dual media filtration and carbon adsorption units (1:10 kg of carbon to soluble material) (HSDB, 2004). Toluene can be removed from water or aqueous waste by air stripping. Practical feed concentrations are limited to about 100 mg/L organics. A properly designed and operated packed-tower air stripper can achieve greater than 99% removal of volatile organics from water. Residuals from an air-stripping process include the treated water, often suitable for reuse, and the contaminated off gas (Freeman, 1989). Overland flow treatment can be an effective method of removing toluene from water. This method is most frequently used in areas where the soils have relatively slow water infiltration rates. Generally, water is allowed to run across the top of a vegetated, gently sloping soil at rates from 6.5 to 40 cm/week; the runoff is collected in ditches and discharged. In a prototype overland flow land treatment system, more than 94% of toluene was removed with an application rate of 0.4 cm/hr at 0.12 m(3)/hr/meter of width (Dragun, 1988).
-ENVIRONMENTAL HAZARD MANAGEMENT
POLLUTION HAZARD
- Toluene enters the environment through petroleum-related industrial processes and through its use in products such as paints, paint thinners, adhesives, fingernail polish, and gasoline. It is also released through solvent spills and leaking underground storage tanks at gasoline storage facilities (ATSDR, 2001; ATSDR, 1994).
Toluene is released into the atmosphere primarily through the volatilization of petroleum fuels and toluene-based solvents and thinners and from motor vehicle exhaust. It is also released into various waste streams through its production and use as an intermediate in the production of benzoic acid, benzaldehyde, benzene, explosives, dyes, and many other organic compounds. Toluene may also enter the environment from volcanic emissions, forest fires, and crude oil (HSDB, 2004).
- Toluene has been measured in urban air at levels from 0.01 to 0.05 parts per million. It is likely released from manufacturing sites, automobile and coke-oven emissions, gasoline evaporation, and cigarette smoke (Bingham et al, 2001).
ENVIRONMENTAL FATE AND KINETICS
Toluene's high vapor pressure indicates that it will exist solely as a vapor in the ambient atmosphere (HSDB, 2004). When released into the atmosphere, toluene will undergo degradation via photochemically produced hydroxyl radicals. Reactions of toluene with nitrate radicals and ozone molecules may also cause degradation in the atmosphere, however, these reactions are generally considered too slow to be environmentally important (HSDB, 2004; Verschueren, 2001). Based on measured rate data for the vapor phase reaction with hydroxyl radicals in air, the photo-oxidation half-life of toluene in air ranges from 10 h to 104 h (4.3 days) (Howard et al, 1991). The estimated half-life for toluene in air, based on photochemical reactions with hydroxyl radicals is 3 days (HSDB, 2004; Verschueren, 2001). The half-life of toluene in outdoor air with a hydroxyl radical level of 5 x 10(-8) parts per million is 1 day; for the total troposphere with the same level of hydroxyl radicals, its half-life is 2.5 days. Reported rate constants (Koh) for toluene with hydroxyl radicals range from 8550 to 9479 (Verschueren, 2001).
The half-life of toluene for the nighttime reaction with nitrate radicals is estimated to be about 491 days, calculated from its measured rate constant of 6.8 x 10 (-17)cm(3)/molecule-sec at 25 degrees C for the vapor-phase reaction (HSDB, 2004). The half-life of toluene through reaction with ozone molecules is estimated to be 27,950 days (approximately 76 years) (HSDB, 2004; Verschueren, 2001). The estimated half-life of toluene in photochemical smog conditions (in Southeast England) is 5.8 hours (Verschueren, 2001).
SURFACE WATER Rapid volatilization of toluene from water surfaces is expected to be an important fate process, given a Henry's law constant of 6.64 x 10(-3) atm-m(3)/mol and a vapor pressure of 28.4 mmHg at 25 degrees C (HSDB, 2004). The half-life of toluene in water has been reported as 4 and 56 days for aerobic and anaerobic conditions, respectively (HSDB, 2004). Based on measured rate data for hydroxyl radicals in aqueous solution, the photo-oxidation half-life of toluene in water ranges from 321 h (13 days) to 1284 h (54 days) (Howard et al, 1991). First-order degradation rate constants for toluene in gasoline-contaminated water have been measured at 5 x 10(-4) and 6.3 x 10(-3)/day (HSDB, 2004). Toluene is not expected to adsorb to particulate matter in water (HSDB, 2004).
GROUND WATER Based on unacclimated grab sample data of aerobic soil from ground water aquifers, the half-life of toluene in ground water ranges from 168 h (7 days) to 672 h (4 weeks) (Howard et al, 1991). A first-order biodegradation rate constant of 0.045/day has been reported for toluene in a petroleum-contaminated aquifer under anaerobic conditions (HSDB, 2004).
TERRESTRIAL Rapid volatilization of toluene is expected from soil surfaces given a Henry's law constant is 6.64 x 10(-3) atm-m(3)/mol and a vapor pressure of 28.4 mmHg at 25 degrees C (HSDB, 2004). Approximately 40% to 70% of the toluene applied to sandy soil surfaces is volatilized (HSDB, 2004). In soil, toluene's adsorption is inversely proportional to the soil pH. Measured soil partition coefficients range from 37 to 178, indicating it will have moderate to high mobility in soils (HSDB, 2004).
OTHER Toluene concentrations of 1 g/L in methanol did not absorb UV light at wavelengths greater than 280 nanometers (nm). The lambda max light absorption is 268 nm, 264 nm, 261 nm, 259.5 nm, 255 nm, and 253.5 nm (Howard et al, 1991).
ABIOTIC DEGRADATION
- Toluene's high vapor pressure indicates that it will exist solely as a vapor in the ambient atmosphere. While reactions of toluene with nitrate radicals and ozone molecules may cause degradation in the atmosphere, these reactions are generally considered too slow to be environmentally important. Toluene is not expected to undergo hydrolysis in the environment or to directly photolyze
- Volatilization from water surfaces is expected to be an important fate process for toluene, based on toluene's reported vapor pressure (28.4 mmHg at 25 degrees C) and Henry's law constant (6.64 x 10(-3) atm-m(3)/mol). Toluene's half-life in water has been reported at 4 and 56 days for aerobic and anaerobic conditions, respectively
Toluene's half-life in groundwater reportedly ranges from 7 days to 4 weeks (based on unacclimated grab sample data of aerobic soil from ground water aquifers) (Howard et al, 1991). For a marine mesocosm, degradation half-lives of 1.5 to 16 days for toluene have been reported (Verschueren, 2001).
- Toluene is expected to rapidly volatilize from moist soil surfaces. Volatilization from dry soil surfaces may also occur. Toluene is expected to be moderately to highly mobile in soil based on measured soil partition coefficients of 37 to 178 (HSDB, 2004; Verschueren, 2001).
- Complete biodegradation of toluene in soils has been observed under laboratory conditions. Its degradation rate is much faster in soils previously contaminated with toluene (HSDB, 2004). Toluene can also suppress or inhibit microbial activity in soil and thereby adversely affect various soil biodegradation processes (nitrification, respiration, ammonification) (Verschueren, 2001).
BIODEGRADATION
Complete biodegradation of toluene in soils has been observed under laboratory conditions. The rate of degradation is faster in soils previously contaminated with toluene (HSDB, 2004). Findings on biodegradation half-lives for toluene in soil using various inoculum included the following (Dragun, 1988): Half-life estimates of 37 and 39 days and 100% degradation in 80 days based on field observations of a naturally occurring soil-groundwater system. A half-life estimate of 37 days based on ground water incubation studies using natural microbial flora as the inoculum. Degradation at 100% in 10 days in batch test using groundwater with natural microbial flora as the inoculum. Degradation percentages of 100% in 30 to 80 days and more than 99% in 120 weeks in soil incubation studies using natural microbial flora as the inoculum. Estimated degradation at 100% in 80 days based on field observation of a naturally occurring soil-groundwater system. Per week degradation percentage estimates of more than 93% and from 0.9% to 3.2% in soil incubation studies using natural microbial flora as the inoculum.
Other findings on toluene biodegradation in soil include: Biodegradation half-lives can range from several hours to 71 days for toluene in various soils (HSDB, 2004). Reported degradation half-lives for toluene in soil are 0.7 to 1.7 days and 7 days (Verschueren, 2001). Other reported half-lives for toluene in soil range from 96 h (4 days) to 528 h (22 days) based on estimated aqueous aerobic biodegradation (Howard et al, 1991). Reported degradation half-lives for toluene in various types of nonadapted aerobic subsoils include the following (Verschueren, 2001): In sand (Oklahoma): 1.6, 9, 115, and 539 days In sand (Ontario): 48 days In coarse sand (Oklahoma): greater than 485 days In clay (Oklahoma): 161 days In sand (Texas): 121 days
Toluene disappeared from soil in less than 2 days under aerobic laboratory conditions at 20 degrees C; initial concentrations of toluene were 100 mg/kg (Verschueren, 2001). Toluene degradation at 100% in 192 h at 13 degrees C (initial toluene concentration of 2.2 mcg/L) in a soil percolation study using natural microbial flora in the groundwater as the inoculum. Test conditions included presence of other high-octane gasoline components at 100 mcg/L (Dragun, 1988; Verschueren, 2001).
Toluene can impact microbial biodegradation processes as follows (Verschueren, 2001): 30 mg/L toluene inhibits glucose degradation by Pseudomonas fluorescens and 200 mg/L inhibits glucose degradation by E. coli. greater than 50,000 mg/kg toluene in soil suppresses biodegradation activity by various soil microorganisms. 360 to 1300 mg/kg in soil has no observable effects (NOEC-5h) on soil respiration. 100 to 1000 mg/kg and 26 mg/kg or less in soil show no observable effects (NOEC-28 days) on ammonification or soil nitrification, respectively. 300 to 1000 mg/kg (wet) and 20 mg/kg (wet) or less in a loam/sand soil reportedly showed no observable effects (NOEC) on microbial respiration (+/- glucose) and nitrification, respectively.
The white rot fungus Phanerochaete chrysosporium was demonstrated to degrade toluene and chlorobenzene when in mixture; hence, methyl- as well as chloro-substituted benzenes were simultaneously degraded (Yadav et al, 1995).
BIOACCUMULATION
ALGAE (Selenastrum capricornutum): 98 (BCF) (Verschueren, 2001) ALGAE (Chlorella fusca): 380 (BCF, wet wt) (Verschueren, 2001) MUSSELS (Mytilus edulis): 4.2 (BCF) (Verschueren, 2001) EELS (Anguilla japonica): 13 (BCF); half-life period of 1.4 days (Verschueren, 2001) FATHEAD MINNOW: 91 (BCF) (Verschueren, 2001) GOLDFISH: 8 (BCF) (Verschueren, 2001) GOLDEN IDE FISH: 90 (BCF) (HSDB, 2004) Bioconcentration of toluene in aquatic organisms is expected to be low to moderate (HSDB, 2004).
ENVIRONMENTAL TOXICITY
- LC100: (WATER) COHO SALMON, Young: 50 mg/L for 48 to 96H (Verschueren, 2001)
- LC100: (WATER) TETRAHYMENA PYRIFORMIS (ciliate): 550 mg/L for 24H (Verschueren, 2001)
- LC100: (WATER) COHO SALMON, Young: 100 mg/L for 48 to 96H (Verschueren, 2001)
- LC93: (WATER) COHO SALMON, Young: 100 mg/L for 24H (Verschueren, 2001)
- LC90: (WATER) COHO SALMON, Young: 50 mg/L for 24H (Verschueren, 2001)
- LC50: (WATER) AEDES AEGYPTI, 4th instar (mosquito larvae): 22 mg/L (Verschueren, 2001)
- LC50: (WATER) ARTEMIA SALINA (brine shrimp): 33 mg/L for 24H (HSDB, 2004)
- LC50: (WATER) BLUEGILL: 17 mg/L for 24H and 13 mg/L for 96H, 95% confidence limit 11 to 15 mg/L at 21 to 23 degrees C (HSDB, 2004)
- LC50: (WATER) BLUEGILL: 24 mg/L for 24 to 96H (Verschueren, 2001)
- LC50: (WATER) CANCER MAGISTER (crab larvae, stage I): 28 mg/L for 96H (Verschueren, 2001)
- LC50: (AIR) CALANDRA GRANARIA (grain weevil): 210 mg/L (HSDB, 2004)
- LC50: (WATER) CARASSIUS AURATUS (goldfish): 57.68 mg/L for 96H, 95% confidence limits = 48.87 to 68.75 mg/L (HSDB, 2004)
- LC50: (WATER) CARASSIUS AURATUS (goldfish): 58 mg/L for 24H to 96H (Verschueren, 2001)
- LC50: (WATER) CARASSIUS AURATUS, Female (goldfish): 23 mg/L for 96H, water at 17 to 19 degrees C (Verschueren, 2001)
- LC50: (WATER) CARASSIUS AURATUS, Female (goldfish): 15 mg/L for 720H, water at 17 to 19 degrees C (Verschueren, 2001)
- LC50: (WATER) CHANNEL CATFISH: 240 mg/L for 96H (HSDB, 2004)
- LC50: (WATER) CHIRONOMUS RIPARIUS, 3rd instar larvae: 47 mg/L for 48H (Verschueren, 2001)
- LC50: (WATER) CRANGON FRANCISCORUM (shrimp): 4.3 mg/L for 96H (Verschueren, 2001)
- LC50: (WATER) CYPRINODON VARIEGATUS (sheepshead minnow): 277 to 485 mg/L for 96H (HSDB, 2004)
- LC50: (WATER) CYPRINODON VARIEGATUS (sheepshead minnow): greater than 280 but less than 480 mg/L for 96H (Verschueren, 2001)
- LC50: (WATER) CYPRINODON VARIEGATUS, juvenile (sheepshead minnow): 13 mg/L for 96H (Verschueren, 2001)
- LC50: (WATER) DAPHNIA MAGNA (water flea): 313 mg/L for 48H (HSDB, 2004)
- LC50: (WATER) DAPHNIA MAGNA (water flea): 11.5 mg/L for 48H (Verschueren, 2001)
- LC50: (SOIL) EISENIA FOETIDA (worm): greater than 150 but less than 280 mg/kg for 2 to 4W (Verschueren, 2001)
- LC50: (SOIL) EISENIA FOETIDA (worm): greater than 100 but less than 180 mg/kg for 2W (Verschueren, 2001)
- LC50: (SOIL) EISENIA FOETIDA (worm): greater than 100 but less than 180 mg/kg for 4W (Verschueren, 2001)
- LC50: (WATER) EUALUS spp. (shrimp): 21 mg/L for 96H, water at 4 degrees C, static test (Verschueren, 2001)
- LC50: (WATER) EUALUS spp. (shrimp): 20 mg/L for 96H, water at 8 degrees C, static test (Verschueren, 2001)
- LC50: (WATER) EUALUS spp. (shrimp): 15 mg/L for 96H, water at 12 degrees C, static test (Verschueren, 2001)
- LC50: (WATER) LEBISTES RETICULATUS (guppy): 63 to 59 mg/L for 24 to 96H (Verschueren, 2001)
- LC50: (WATER) LEBISTES RETICULATUS (guppy): 59.30 mg/L for 96H, 95% confidence limits = 50.87 to 70.34 mg/L (HSDB, 2004)
- LC50: (WATER) LEPOMIS MACROCHIRUS: 13 mg/L for 96H (Verschueren, 2001)
- LC50: (WATER) MORONE SAXATILIS (striped bass): 7.3 mg/L for 96H (HSDB, 2004; Verschueren, 2001)
- LC50: (WATER) MOSQUITO FISH: 1280 to 1340 mg/L for 24 to 96H (Verschueren, 2001)
- LC50: (WATER) MYSIDOPSIS BAHIA: 56 mg/L for 96H (Verschueren, 2001)
- LC50: (WATER) NITOCRA SPINIPES (copepod): 24.2 to 74.2 mg/L for 24H (HSDB, 2004)
- LC50: (WATER) ONCORHYNCHUS GORBUSCHA (pink salmon): 6.4 mg/L for 96H, water at 4 degrees C, static test (Verschueren, 2001)
- LC50: (WATER) ONCORHYNCHUS GORBUSCHA (pink salmon): 7.6 mg/L for 96H, water at 8 degrees C, static test (Verschueren, 2001)
- LC50: (WATER) ONCORHYNCHUS GORBUSCHA (pink salmon): 8.1 mg/L for 96H, water at 12 degrees C, static test (Verschueren, 2001)
- LC50: (WATER) ONCORHYNCHUS KISUTCH: 5.5 mg/L for 96H (Verschueren, 2001)
- LC50: (WATER) PALAEMONETES PUGIO (grass shrimp): 9.5 mg/L for 96H (Verschueren, 2001)
- LC50: (WATER) PIMEPHALES PROMELAS (fathead minnow): 34.27 mg/L for 96H, 95% confidence limits = 22.83 to 45.86 mg/L (HSDB, 2004)
- LC50: (WATER) PIMEPHALES PROMELAS (fathead minnow): 56 to 34 mg/L for 24 to 96H (Verschueren, 2001)
- LC50: (WATER) PIMEPHALES PROMELAS (fathead minnow): 55 to 72 mg/L (embryos), 25 to 36 mg/L (1-day posthatch protolarvae), and 26 to 31 mg/L (30-day-old minnows) for 96H (HSDB, 2004)
- LC50: (WATER) PIMEPHALES PROMELAS (fathead minnow): 55 to 72 mg/L (embryos), 28 to 36 mg/L (larvae), and 18 to 30 mg/L and 34 to 42 (30-day-old minnows) for 96H (Verschueren, 2001)
- LC50: (WATER) PIMEPHALES PROMELAS (fathead minnow): 36.2 mg/L for 96H, confidence limit 29.4 to 44.6 mg/L, flow-through bioassay with measured concentrations at 24.7 degrees C, dissolved oxygen 6.9 mg/L, hardness 45.4 mg/L calcium carbonate, alkalinity 43.4 mg/L calcium carbonate, and pH 7.89 (HSDB, 2004)
- LC50: (WATER) POECILIA RETICULATA, 2 to 3 months old (guppy): 68 mg/L for 14 days (Verschueren, 2001)
- LC50: (WATER) POECILIA RETICULATA (guppy): 28 mg/L for 4 days (Verschueren, 2001)
- LC50: (WATER) SCYLLA SERRATA: 149 mg/L for 96H (Verschueren, 2001)
- LC: (WATER) SUNFISH: 61 ppm for 1H (OHM/TADS, 2002)
- LC: (WATER) SUNFISH: 22-65 ppm for 1H (OHM/TADS, 2002)
- IC50: (WATER) DAPHNIA MAGNA (water flea): 7 mg/L for 24H (Verschueren, 2001)
- EC50: (WATER) CYPRINODON VARIEGATUS (sheepshead minnow): 7.7 mg/L for 28 days; growth inhibition (Verschueren, 2001)
- EC50: (WATER) DAPHNIA MAGNA (water flea): 270 mg/L for 24H (Verschueren, 2001)
- EC50: (WATER) DAPHNIA MAGNA (water flea): 15 mg/L for 48H (Verschueren, 2001)
- EC50: (WATER) DAPHNIA MAGNA (water flea): 3.8 mg/L for 16H; immobilization (Verschueren, 2001)
- EC50: (WATER) DAPHNIA MAGNA (water flea): 1.4 mg/L for 16 days; effects on reproduction (Verschueren, 2001)
- EC50: (WATER) DAPHNIA MAGNA (water flea): 2.8 mg/L; growth inhibition (Verschueren, 2001)
- EC50: (WATER) DUNALIELLA BIOCULA (algae): greater than 40 mg/L for 4H; inhibited photosynthesis (Verschueren, 2001)
- EC50: (WATER) DUNALIELLA BIOCULA (algae): 14 mg/L for 8 days; affected growth (Verschueren, 2001)
- EC50: (WATER) ONCORHYNCHUS KISUTCH: 2.8 mg/L for 40 days; growth inhibition (Verschueren, 2001)
- EC50: (WATER) PIMEPHALES PROMELAS (fathead minnow): 14.6 mg/L for 96H, confidence limits = 14 to 15.1 mg/L, flow-through bioassay with measured concentrations at 24.7 degrees C, dissolved oxygen 6.9 mg/L, hardness 45.4 mg/L calcium carbonate, alkalinity 43.4 mg/L calcium carbonate, and pH 7.89; effect: loss of equilibrium (HSDB, 2004)
- EC50: (WATER) PIMEPHALES PROMELAS (fathead minnow): 6 mg/L for 32 days; growth inhibition (Verschueren, 2001)
- EC50: (WATER) SALMO GAIRDNERI: 5.8 mg/L for 4 days; growth inhibition (Verschueren, 2001)
- EC50: (WATER) SAROTHERONDON MOSSAMBICA: 25 mg/L for 70 days; affected various enzymes, unspecified (Verschueren, 2001)
- EC50: (WATER) SELENASTRUM CAPRICORNUTUM: 12 mg/L for 3 days; growth inhibition (Verschueren, 2001)
- EC75: (WATER) MACROCYSTIS ANGUSTIFOLIA (kelp): 10 mg/L for 96H; affected photosynthesis (OHM/TADS, 2002)
- TLM: (WATER) BLUEGILL: 24 ppm for 96H, temperature-controlled bioassay (OHM/TADS, 2002)
- TLM: (WATER) BRINE SHRIMP: 33 ppm for 24H, static bioassay (OHM/TADS, 2002)
- TLM: (WATER) FATHEAD MINNOW: 44 ppm for 96H, temperature-controlled bioassay (OHM/TADS, 2002)
- TLM: (WATER) GOLDFISH: 6.2 ppm for 96H, temperature controlled bioassay (OHM/TADS, 2002)
- TLM: (WATER) GUPPY: 66 ppm for 96H, temperature controlled bioassay (OHM/TADS, 2002)
- TLM: (WATER) MOSQUITO FISH: 1340 ppm for 24H, temperature 20 degrees C (OHM/TADS, 2002)
- TLM: (WATER) MOSQUITO FISH: 1260 ppm for 48H, temperature 20 degrees C (OHM/TADS, 2002)
- TLM: (WATER) MOSQUITO FISH: 1180 ppm for 96H, temperature 20 degrees C (OHM/TADS, 2002)
- INHIBITORY: (WATER) MACROCYSTIS PYRIFERA: 10 ppm (OHM/TADS, 2002)
- INHIBITORY: (WATER) SCENEDESMUS: 120 (OHM/TADS, 2002)ppm
- THRESHOLD: (WATER) DAPHNIA: 60 ppm (OHM/TADS, 2002)
- Toluene is dangerous to aquatic life in high concentrations (CHRIS , 2002).
-PHYSICAL/CHEMICAL PROPERTIES
MOLECULAR WEIGHT
DESCRIPTION/PHYSICAL STATE
- Toluene is a highly volatile and colorless, clear refractive liquid with a sweet, pungent aromatic odor (Budavari, 2000; CHRIS , 2002). Its odor has also been described as a sour or burnt (Verschueren, 2001).
VAPOR PRESSURE
- 36.7 mmHg (at 30 degrees C) (Lewis, 2000; OHM/TADS , 2002)
- 36.7 mmHg (NL-TP) (Bingham et al, 2001)
- 22 mmHg (at 20 degrees C) (NFPA, 1997; Verschueren, 2001)
- 10 mmHg (at 6.4 degrees C) (Verschueren, 2001)
- 40 mmHg (at 31.8 degrees C) (Verschueren, 2001)
- 200 mmHg (at 69.5 degrees C) (OHM/TADS , 2002)
- 28.4 mmHg (at 25 degrees C) (HSDB , 2002)
SPECIFIC GRAVITY
- OTHER TEMPERATURE AND/OR PRESSURE
0.866 (at 20/4 degrees C) (Budavari, 2000; ITI, 1995; Lewis, 2000; OHM/TADS , 2002)
- TEMPERATURE AND/OR PRESSURE NOT LISTED
0.87 (Bingham et al, 2001; NFPA, 1997; NIOSH, 2002) 0.9 (NFPA, 1997) 0.8869 (at 20.4 degrees C) (Bingham et al, 2001)
FREEZING/MELTING POINT
-139 degrees F; -95 degrees C; 178.2 K (CHRIS , 2002; Lewis, 2000; NIOSH, 2002) -94.99 degrees C (Bingham et al, 2001)
-95 to -94.5 degrees C (Lewis, 2000) -95 degrees C; -139 degrees F (Bingham et al, 2001; Budavari, 2000; ILO, 1998; ITI, 1995; NFPA, 1997; OHM/TADS , 2002) 178.16 K (Lide, 1993) -95.1 degrees C (Verschueren, 2001) -94.9 degrees C (HSDB , 2002)
BOILING POINT
- 110.6 degrees C (Budavari, 2000; ITI, 1995; OHM/TADS , 2002)
- 110.4 degrees C (closed cup) (Lewis, 2000)
- 383.78 K (at 101.325 kPa) (Lide, 1993)
- 232 degrees F; 111 degrees C (NFPA, 1997; NIOSH, 2002)
- 231.1 degrees F; 110.6 degrees C; 383.8 K (CHRIS , 2002)
- 110.8 degrees C (Verschueren, 2001)
- 110.62 degrees C (Bingham et al, 2001)
- 111 degrees C (ILO, 1998)
FLASH POINT
- 4.4 degrees C; 40 degrees F (closed cup) (AAR, 2000; Bingham et al, 2001; Budavari, 2000; CHRIS , 2002; ITI, 1995; Lewis, 2000; NFPA, 1997; NIOSH, 2002)
- 4 degrees C (Pohanish & Greene, 1997)
- 4 degrees C (closed cup) (ILO, 1998)
- 55 degrees F (open cup) (CHRIS , 2002)
AUTOIGNITION TEMPERATURE
- 996 degrees F (Lewis, 2000)
- 480 degrees C; 896 degrees F (CHRIS , 2002; ILO, 1998; NFPA, 1997)
- 536 degrees C (ITI, 1995)
- 536.11 degrees C (OHM/TADS , 2002)
EXPLOSIVE LIMITS
1.27% (CHRIS , 2002; Lewis, 2000) 1.2% (ILO, 1998; NFPA, 1997; OHM/TADS , 2002) 1.1% (NIOSH, 2002) 1.4% (Bingham et al, 2001; ITI, 1995)
7% (CHRIS , 2002; Lewis, 2000) 7.1% (ILO, 1998; NFPA, 1997; NIOSH, 2002; OHM/TADS , 2002) 6.7% (ITI, 1995) 7.9% (Bingham et al, 2001)
SOLUBILITY
This compound is very slightly soluble in water (Budavari, 2000; ILO, 1998). Solubility in water at 23.5 degrees C (w/w): 0.067% (Budavari, 2000) 0.07% (at 74 degrees F) (NIOSH, 2002) 470 mg/L (at 16 degrees C) (Verschueren, 2001) 515 mg/L (at 20 degrees C) (Verschueren, 2001) 526 mg/L (at 25 degrees C) (HSDB , 2002)
This compound is insoluble in water (Bingham et al, 2001; Lewis, 2000; ITI, 1995).
This compound is miscible with alcohol, chloroform, ether, acetone, glacial acetic acid, and carbon disulfide (Budavari, 2000; ITI, 1995). It is miscible with most organic solvents (Ashford, 1994). This compound is soluble in acetone and miscible in absolute alcohol, ether, and chloroform (Bingham et al, 2001; Lewis, 2000).
OCTANOL/WATER PARTITION COEFFICIENT
- log Kow = 2.65 (Montgomery & Welkom, 1990)
- log Kow = 2.69 (Montgomery & Welkom, 1990)
- log Kow = 2.21 (Montgomery & Welkom, 1990)
- log Kow = 2.63 (Montgomery & Welkom, 1990)
- log Kow = 2.5 (Montgomery & Welkom, 1990)
- log Kow = 2.11 (Montgomery & Welkom, 1990)
- log Kow = 2.8 (Montgomery & Welkom, 1990)
- log Kow = 2.79 (Montgomery & Welkom, 1990)
- log Kow = 2.73 (HSDB , 2002)
HENRY'S CONSTANT
- 0.0067 atm-m(3)/mol (Montgomery & Welkom, 1990)
- 0.00674 atm-m(3)/mol (at 25 degrees C) (Montgomery & Welkom, 1990)
SPECTRAL CONSTANTS
OTHER/PHYSICAL
- NUCLEAR MAGNETIC RESONANCE
-REFERENCES
GENERAL BIBLIOGRAPHY- 40 CFR 372.28: Environmental Protection Agency - Toxic Chemical Release Reporting, Community Right-To-Know, Lower thresholds for chemicals of special concern. National Archives and Records Administration (NARA) and the Government Printing Office (GPO). Washington, DC. Final rules current as of Apr 3, 2006.
- 40 CFR 372.65: Environmental Protection Agency - Toxic Chemical Release Reporting, Community Right-To-Know, Chemicals and Chemical Categories to which this part applies. National Archives and Records Association (NARA) and the Government Printing Office (GPO), Washington, DC. Final rules current as of Apr 3, 2006.
- 49 CFR 172.101 - App. B: Department of Transportation - Table of Hazardous Materials, Appendix B: List of Marine Pollutants. National Archives and Records Administration (NARA) and the Government Printing Office (GPO), Washington, DC. Final rules current as of Aug 29, 2005.
- 49 CFR 172.101: Department of Transportation - Table of Hazardous Materials. National Archives and Records Administration (NARA) and the Government Printing Office (GPO), Washington, DC. Final rules current as of Aug 11, 2005.
- 62 FR 58840: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 1997.
- 65 FR 14186: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2000.
- 65 FR 39264: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2000.
- 65 FR 77866: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2000.
- 66 FR 21940: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2001.
- 67 FR 7164: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2002.
- 68 FR 42710: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2003.
- 69 FR 54144: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2004.
- AAR: Emergency Handling of Hazardous Materials in Surface Transportation, Bureau of Explosives, Association of American Railroads, Washington, DC, 2000.
- ACGIH: Documentation of the Threshold Limit Values and Biological Exposure Indices, 6th ed, Am Conference of Govt Ind Hyg, Inc, Cincinnati, OH, 1991, pp 1568-1580.
- ACGIH: Documentation of the Threshold Limit Values and Biological Exposure Indices, 7th ed, Am Conference of Govt Ind Hyg, Inc, Cincinnati, OH, 2001.
- AIHA: 2006 Emergency Response Planning Guidelines and Workplace Environmental Exposure Level Guides Handbook, American Industrial Hygiene Association, Fairfax, VA, 2006.
- ATSDR: Is there a medical test to determine whether I have been exposed to toluene?, Agency for Toxic Substances and Disease Registry, US Dept of Health and Human Services, Atlanta, GA, 1994.
- ATSDR: Toxicological Profile for Polychlorinated Biphenyls. US Dept, Agency for Toxic Substances and Disease Registry, US Dept of Health and Human Services, Atlanta, GA, 2001.
- Alaspaa AO, Kuisma MJ, Hoppu K, et al: Out-of-hospital administration of activated charcoal by emergency medical services. Ann Emerg Med 2005; 45:207-12.
- Aleguas A, Linakis JG, & Lewander WJ: Bell's palsy associated with toluene exposure (Abstract). Vet Human Toxicol 1991; 33:372.
- Allister C, Lush M, & Oliver JS: Status epilepticus caused by solvent abuse. Br Med J 1981; 283:1156.
- Ameno K, Fuke C, & Ameno S: A fatal case of oral ingestion of toluene. Forensic Sci Internat 1989; 41:255-260.
- Ameno K, Kiriu T, & Fuke C: Regional brain distribution of toluene in rats and in a human autopsy. Arch Toxicol 1992; 66:153-156.
- American Conference of Governmental Industrial Hygienists : ACGIH 2010 Threshold Limit Values (TLVs(R)) for Chemical Substances and Physical Agents and Biological Exposure Indices (BEIs(R)), American Conference of Governmental Industrial Hygienists, Cincinnati, OH, 2010.
- Amorim LC & Alvarez-Leite EM: Determination of o-cresol by gas chromatography and comparison with hippuric acid levels in urine samples of individuals exposed to toluene. J Toxicol Environ Health 1997; 50:401-407.
- Angerer J & Kramer A: Occupational chronic exposure to organic solvents .16. ambient and biological monitoring of workers exposed to toluene. Int Arch Occup Environ Health 1997; 69:91-96.
- Angerer J, Schildbach M, & Kramer A: S-p-toluylmercapturic acid in the urine of workers exposed to toluene: a new biomarker of toluene exposure. Arch Toxicol 1998; 72:119-123.
- Anon: Department of Labor-Occupational exposure to toluene. Federal Register 1975; 40:46206.
- Ansell-Edmont: SpecWare Chemical Application and Recommendation Guide. Ansell-Edmont. Coshocton, OH. 2001. Available from URL: http://www.ansellpro.com/specware. As accessed 10/31/2001.
- Arai H, Yamada M, & Miyake S: Two cases of toluene embryopathy with severe motor and intellectual disabilities syndrome.(Japanese). No to Hattatsu (Brain & Development) 1997; 29:361-366.
- Arnold GL, Kirby RS, & Langendoerfer S: Toluene embryopathy - clinical delineation and developmental follow-up. Pediatrics 1994; 93:216-220.
- Arthur LJ & Curnock DA: Xylene-induced epilepsy following innocent glue sniffing (Letter). Br Med J 1982; 284:1787.
- Artigas A, Bernard GR, Carlet J, et al: The American-European consensus conference on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling.. Am J Respir Crit Care Med 1998; 157:1332-1347.
- Ashford RD: Ashford's Dictionary of Industrial Chemicals, Wavelength Publications, London, United Kingdom, 1994.
- Ashikaga R, Araki Y, & Miura K: Cranial MRI in chronic thinner intoxication. Neuroradiol 1995; 37:443-444.
- Baelum J, Molhave L, & Hansen SH: Hepatic metabolism of toluene after gastrointestinal uptake in humans. Scand J Work Environ Health 1993; 19:55-62.
- Bartolucci G & Pellettier JR: Glue sniffing and movement disorder. J Neurol Neurosurg Psychiatr 1984; 47:1259.
- Baselt RC: Biological Monitoring Methods for Industrial Chemicals, 2nd ed, PSG Publishing Company, Littleton, MA, 1988.
- Baselt RC: Disposition of Toxic Drugs and Chemical in Man, 5th ed, Chemical Toxicology Institute, Foster City, CA, 2000a.
- Baselt RC: Disposition of Toxic Drugs and Chemicals in Man, 5th ed, Chemical Toxicology Institute, Foster City, CA, 2000.
- Basu D: Rep No EPA-600/8-82-008, Office of Health and Environ Assess, USEPA, Washington, DC, 1982, pp 250.
- Bata Shoe Company: Industrial Footwear Catalog, Bata Shoe Company, Belcamp, MD, 1995.
- Baxter PJ, Adams PH, & Aw TC: Hunter's Diseases of Occupations, 9th ed, Oxford University Press Inc, New York, NY, 2000.
- Bergman K: Whole-body autoradiography and allied tracer techniques in distribution and elimination studies of some organic solvents: benzene, toluene, xylene, styrene, methylene chloride, chloroform, carbon tetrachloride and trichloroethylene. Scand J Work Environ Health 1979; 5(Suppl 1):29-53.
- Best Manufacturing: ChemRest Chemical Resistance Guide. Best Manufacturing. Menlo, GA. 2002. Available from URL: http://www.chemrest.com. As accessed 10/8/2002.
- Best Manufacturing: Degradation and Permeation Data. Best Manufacturing. Menlo, GA. 2004. Available from URL: http://www.chemrest.com/DomesticPrep2/. As accessed 04/09/2004.
- Bingham E, Cohrssen B, & Powell CH: Patty's Toxicology, Vol 4. 5th ed, John Wiley & Sons, New York, NY, 2001.
- Bonzel KE, Muller-Wiefel DE, & Ruder H: Anti-glomerular basement membrane antibody-mediated glomerulonephritis due to glue sniffing. Eur J Pediatr 1987; 146:296-300.
- Boon NA: Solvent abuse and the heart. Br Med J 1987; 294:722.
- Bos RP: Mutat Res 1981; 88:273.
- Bosch X, Campistol JM, & Montoliu J: Myelofibrosis and focal segmental glomerulosclerosis associated with toluene poisoning. Human Toxicol 1988; 7:357-361.
- Boss Manufacturing Company: Work Gloves, Boss Manufacturing Company, Kewanee, IL, 1998.
- Brower RG, Matthay AM, & Morris A: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Eng J Med 2000; 342:1301-1308.
- Brown CV, Rhee P, Chan L, et al: Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?. J Trauma 2004; 56(6):1191-1196.
- Brugnone F: Toluene concentrations in the blood and alveolar air of workers during the workshift and the morning after. Br J Ind Med 1986; 43:56-61.
- Budavari S: The Merck Index, 12th ed, Merck & Co, Inc, Whitehouse Station, NJ, 1996, pp 1626.
- Budavari S: The Merck Index, 12th ed. on CD-ROM. Version 12:3a. Chapman & Hall/CRCnetBASE. Whitehouse Station, NJ. 2000.
- Burgess JL, Kirk M, Borron SW, et al: Emergency department hazardous materials protocol for contaminated patients. Ann Emerg Med 1999; 34(2):205-212.
- Byrne A & Zibin T: Toluene-related psychosis (Letter). Br J Psychiatry 1991; 158:578.
- CESARS : Chemical Evaluation Search and Retrieval System, (CD-ROM Version). Ontario Ministry of the Environment and Michigan Department of Natural Resources, Canadian Centre for Occupational Health and Safety. Hamilton, Ontario. 1990.
- CHRIS : CHRIS Hazardous Chemical Data. US Department of Transportation, US Coast Guard. Washington, DC (Internet Version). Edition expires 2002; provided by Truven Health Analytics Inc., Greenwood Village, CO.
- Camp NE: Drug- and toxin-induced Rhabdomyolysis. J Emerg Nurs 2009; 35(5):481-482.
- Caravati EM & Bjerk PJ: Acute toluene ingestion toxicity (letter). Ann Emerg Med 1997; 30:838-839.
- Carder JR & Fuerst RS: Myocardial infarction after toluene inhalation. Ped Emerg Care 1997; 13:117-119.
- Carlsson A: Exposure to toluene: Uptake, distribution and elimination in man. Scand J Work Environ Health 1982; 8:43-55.
- Carlton FB, Seger D, & Welch LW: Chronic neurological sequelae following acute toluene exposure (Abstract 95). Vet Human Toxicol 1989; 31:353.
- Cataletto M: Respiratory Distress Syndrome, Acute(ARDS). In: Domino FJ, ed. The 5-Minute Clinical Consult 2012, 20th ed. Lippincott Williams & Wilkins, Philadelphia, PA, 2012.
- ChemFab Corporation: Chemical Permeation Guide Challenge Protective Clothing Fabrics, ChemFab Corporation, Merrimack, NH, 1993.
- Chemsoft(R) : Electronic EPA, NIOSH, & OSHA Methods(TM). Windowchem(TM) Software. Fairfield, CA. 2000.
- Chowdhury JK: Acute ventilatory failure from sniffing paint. Chest 1977; 71:687-688.
- Chyka PA, Seger D, Krenzelok EP, et al: Position paper: Single-dose activated charcoal. Clin Toxicol (Phila) 2005; 43(2):61-87.
- Clayton GD & Clayton FE: Patty's Industrial Hygiene and Toxicology, Vol 2B, 2C, & 2D. Toxicology, 4th ed, John Wiley & Sons, New York, NY, 1994.
- Clayton GD & Clayton FE: Patty's Industrial Hygiene and Toxicology, Vol 2B, Toxicology, 3rd ed, John Wiley & Sons, New York, NY, 1981.
- Comasec Safety, Inc.: Chemical Resistance to Permeation Chart. Comasec Safety, Inc.. Enfield, CT. 2003. Available from URL: http://www.comasec.com/webcomasec/english/catalogue/mtabgb.html. As accessed 4/28/2003.
- Comasec Safety, Inc.: Product Literature, Comasec Safety, Inc., Enfield, CT, 2003a.
- Council on Scientific Affairs: Effects of Toxic Chemicals on the Reproductive System, American Medical Association, Chicago, IL, 1985.
- Courtney KD, Andrews DE, & Springer J: A perinatal study of toluene in CD-1 mice. Fundam Appl Toxicol 1986; 6:145-154.
- Criddle LM: Rhabdomyolysis. Pathophysiology, recognition, and management. Crit Care Nurse 2003; 23(6):14-22, 24-26, 28.
- Cronk SL, Barkely DEH, & Farrell MF: Respiratory arrest after solvent abuse. Br Med J 1985; 290:897-898.
- Cunningham SR, Dalzell GWN, & McGirr P: Myocardial infarction and primary ventricular fibrillation after glue sniffing (Letter). Br Med J 1987; 294:739-740.
- DFG: List of MAK and BAT Values 2002, Report No. 38, Deutsche Forschungsgemeinschaft, Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area, Wiley-VCH, Weinheim, Federal Republic of Germany, 2002.
- Dagnone D, Matsui D, & Rieder MJ: Assessment of the palatability of vehicles for activated charcoal in pediatric volunteers. Pediatr Emerg Care 2002; 18:19-21.
- Dalgaard M, Hossaini A, & Hougaard KS: Developmental toxicity of toluene in male rats: effects on semen quality, testis morphology and apoptotic neurodegeneration. Arch Toxicol 2001; 75:103-109.
- De Celis R, Feria-Velasco A, & Gonzalez-Unzaga M: Semen quality of workers occupationally exposed to hydrocarbons. Fertil Steril 2000; 73:221-228.
- De Rosa E, Bartolucci GB, Sigon M, et al: Hippuric acid and ortho-cresol as biological indicators of occupational exposure to toluene. Am J Ind Med 1987; 11(5):529-537.
- Deleu D & Hanssens Y: Cerebellar syndrome due to chronic toluene toxicity: beneficial response to amantadine. J Toxicol - Clin Toxicol 2000; 38:37-41.
- Donald J & Hooper K: Developmental toxicity of toluene: evidence from animal and human studies. Arch Environ Health 1991; 46:125.
- Dragun J: The Soil Chemistry of Hazardous Materials, Hazardous Materials Control Research Institute, Silver Spring, MD, 1988.
- DuPont: DuPont Suit Smart: Interactive Tool for the Selection of Protective Apparel. DuPont. Wilmington, DE. 2002. Available from URL: http://personalprotection.dupont.com/protectiveapparel/suitsmart/smartsuit2/na_english.asp. As accessed 10/31/2002.
- DuPont: Permeation Guide for DuPont Tychem Protective Fabrics. DuPont. Wilmington, DE. 2003. Available from URL: http://personalprotection.dupont.com/en/pdf/tyvektychem/pgcomplete20030128.pdf. As accessed 4/26/2004.
- DuPont: Permeation Test Results. DuPont. Wilmington, DE. 2002a. Available from URL: http://www.tyvekprotectiveapprl.com/databases/default.htm. As accessed 7/31/2002.
- Dyer RS, Muller KE, & Janssen R: Neurophysiological effects of 30 day chronic exposure to toluene in rats. Neurobehav Toxicol Teratol 1984; 6:363-368.
- EPA: Search results for Toxic Substances Control Act (TSCA) Inventory Chemicals. US Environmental Protection Agency, Substance Registry System, U.S. EPA's Office of Pollution Prevention and Toxics. Washington, DC. 2005. Available from URL: http://www.epa.gov/srs/.
- ERG: Emergency Response Guidebook. A Guidebook for First Responders During the Initial Phase of a Dangerous Goods/Hazardous Materials Incident, U.S. Department of Transportation, Research and Special Programs Administration, Washington, DC, 2004.
- Ehyai A & Freemon FR: Progressive optic neuropathy and sensorineural hearing loss due to chronic glue sniffing. J Neurol Neurosurg Psychiatr 1983; 46:349-351.
- Einav S, Amitai Y, & Reichman J: Bradycardia in toluene poisoning. Clin Toxicol 1997; 35:295-298.
- Eller N, Netterstrom B, & Laursen P: Risk of chronic effects on the central nervous system at low toluene exposure. Occup Med 1999; 49:389-395.
- Elliot CG, Colby TV, & Kelly TM: Charcoal lung. Bronchiolitis obliterans after aspiration of activated charcoal. Chest 1989; 96:672-674.
- Enzie FD & Colglazier ML: Toluene (methylbenzene) for intestinal nematodes in dogs and cats. Vet Med 1953; 48:325-328.
- Erdman AR & Dart RC: Rhabdomyolysis. In: Dart RC, Caravati EM, McGuigan MA, et al, eds. Medical Toxicology, 3rd ed. Lippincott Williams & Wilkins, Philadelphia, PA, 2004, pp 123-127.
- Euler HH: Arch Gynakol 1967; 204:258-259.
- FDA: Poison treatment drug product for over-the-counter human use; tentative final monograph. FDA: Fed Register 1985; 50:2244-2262.
- Filley CM, Heaton RK, & Rosenberg NL: White matter dementia in chronic toluene abuse. Neurology 1990; 40:532-534.
- Finkel AJ: Hamilton and Hardy's Industrial Toxicology, 4th ed, John Wright, PSG Inc, Boston, MA, 1983, pp 251-252.
- Flanagan RJ, Ruprah M, & Meredith TJ: An introduction to the clinical toxicology of volatile substances. Drug Safety 1990; 5:359-383.
- Foo SC, Phoon WO, & Khoo NY: Toluene in blood after exposure to toluene. Am Ind Hyg Assoc J 1988; 49:255-258.
- Forni A: Arch Environ Health 1971; 22:373-378.
- Freeman HM: Standard Handbook of Hazardous Waste Treatment and Disposal, McGraw-Hill Book Company, New York, NY, 1989.
- Garriot JC: Death among inhalant abusers. Substance Use & Misuse 1997; 32(12 & 13):1871-1876.
- Gerin M, Siemiatycki J, & Desy M: Associations between several sites of cancer and occupational exposure to benzene, toluene, xylene, and styrene: results of a case-control study in Montreal. Am J Ind Med 1998; 34:144-156.
- Gerner-Smidt P & Friedrich U: The mutagenic effect of benzene, toluene and xylene studied by the SCE technique. Mutat Res 1978; 58:313-316.
- Gersberg RM, Korth KG, & Rice LE: Chemical and microbial evaluation of in-situ bioremediation of hydrocarbons in anoxic groundwater enriched with nutrients and nitrate. World J Microbiol Biotechnol 1995; 11:549-558.
- Gibson JE & Hardisty JF: Fundam Appl Toxicol 1983; 3:315-319.
- Gjerde H, Smith-Kielland A, & Normann PT: Driving under the influence of toluene. Forens Sci Internat 1990; 44:77-83.
- Gleich J & Hofmann A: Prenatal toluene inhalation toxicity studies in mice. Unpublished research report (cited in Klimisch et al, 1992), E Merck, Darmstadt, Germany, 1983.
- Goldfrank LR: Goldfrank's Toxicological Emergencies, 6th ed, McGraw-Hill, New York, NY, 1998.
- Golej J, Boigner H, Burda G, et al: Severe respiratory failure following charcoal application in a toddler. Resuscitation 2001; 49:315-318.
- Goodwin TM: Toluene abuse and renal tubular acidosis in pregnancy. Obstet Gynecol 1988; 71:715-718.
- Graff GR, Stark J, & Berkenbosch JW: Chronic lung disease after activated charcoal aspiration. Pediatrics 2002; 109:959-961.
- Grant WM & Schuman JS: Toxicology of the Eye, 4th ed, Charles C Thomas, Springfield, IL, 1993.
- Greenberg MM: The central nervous system and exposure to toluene - a risk characterization. Environ Res 1997; 72:1-7.
- Guardian Manufacturing Group: Guardian Gloves Test Results. Guardian Manufacturing Group. Willard, OH. 2001. Available from URL: http://www.guardian-mfg.com/guardianmfg.html. As accessed 12/11/2001.
- Guenther Skokan E, Junkins EP, & Corneli HM: Taste test: children rate flavoring agents used with activated charcoal. Arch Pediatr Adolesc Med 2001; 155:683-686.
- Gummin DD & Hryhorczuk DO: Hydrocarbons. In: Goldfrank LR, Flomenbaum N, Hoffman RS, et al, eds. Goldfrank's Toxicologic Emergencies. 8th ed., 8th ed. McGraw Hill, New York, NY, 2006, pp -.
- Gupta RK, van der Meulen J, & Johny KV: Oliguric acute renal failure due to glue-sniffing. Scand J Urol Nephrol 1991; 25:247-250.
- Guzelian P, Mills S, & Fallon HJ: Liver structure and function in print workers exposed to toluene. J Occup Med 1988; 30:791-796.
- HSDB : Hazardous Substances Data Bank. National Library of Medicine. Bethesda, MD (Internet Version). Edition expires 2001; provided by Truven Health Analytics Inc., Greenwood Village, CO.
- HSDB : Hazardous Substances Data Bank. National Library of Medicine. Bethesda, MD (Internet Version). Edition expires 2002; provided by Truven Health Analytics Inc., Greenwood Village, CO.
- HSDB : Hazardous Substances Data Bank. National Library of Medicine. Bethesda, MD (Internet Version). Edition expires 2004; provided by Truven Health Analytics Inc., Greenwood Village, CO.
- Haas CF: Mechanical ventilation with lung protective strategies: what works?. Crit Care Clin 2011; 27(3):469-486.
- Hammer KD, Mayer N, & Pfeiffer EH: Sister chromatid exchanges in rotogravure printing plant workers. Int Arch Occup Environ Health 1998; 71:138-142.
- Harbison RM: Hamilton and Hardy's Industrial Toxicology, 5th ed, Mosby, St. Louis, MO, 1998.
- Harris CR & Filandrinos D: Accidental administration of activated charcoal into the lung: aspiration by proxy. Ann Emerg Med 1993; 22:1470-1473.
- Hart LM, Cobaugh DJ, & Dean BS: Successful use of extracorporeal membrane oxygenation (ECMO) in the treatment of refractory respiratory failure secondary to hydrocarbon aspiration (Abstract). Vet Human Toxicol 1991; 33:361.
- Hass U, Lund SP, & Hougaard KS: Developmental neurotoxicity after toluene inhalation exposure in rats. Neurotoxicol Teratol 1999; 21:349-357.
- Hathaway GJ, Proctor NH, & Hughes JP: Chemical Hazards of the Workplace, 4th ed, Van Nostrand Reinhold Company, New York, NY, 1996.
- Hazell WC: Metabolic acidosis associated with volatile substance abuse. Emerg Med 1997; 9:231-236.
- Helliwell M & Murphy M: Drug-induced neurological disease. Br Med J 1979; 1:1283-1284.
- Hersh JH, Podruch PE, & Rogers G: Toluene embryopathy. J Pediatr 1985; 106:922-927.
- Hersh JH: Toluene embryopathy: two new cases. J Med Genet 1989; 26:333-337.
- Hobara T, Okuda M, & Gotoh M: Estimation of the lethal toluene concentration from the accidental death of painting workers. Ind Heath 2000; 38:228-231.
- Holmberg PC: Lancet II 1979; 177-179.
- Holz O, Scherer G, & Brodtmeier S: Determination of low level exposure to volatile aromatic hydrocarbons and genotoxic effects in workers at a styrene plant. Occup Environ Med 1995; 52:420-428.
- Homsi E, Barreiro MF, Orlando JM, et al: Prophylaxis of acute renal failure in patients with rhabdomyolysis. Ren Fail 1997; 19(2):283-288.
- Howard PH, Boethling RS, & Jarvis WF: Handbook of Environmental Degradation Rates, Lewis Publishers, Chelsea, MI, 1991.
- Howell SR, Christian JE, & Isom GE: The hepatotoxic potential of combined toluene-chronic ethanol exposure. Arch Toxicol 1986; 59:45-50.
- Hudak A & Ungvary G: Embryotoxic effects of benzene and its methyl derivatives, toluene and xylene. Toxicology 1978; 11:55-63.
- Hudak A: Orsz Munka-Uzemegeszsegugyi Intez, Budapest, Hung. Munkavedelem 1977; 23(Suppl):25-30.
- Huerta-Alardin AL, Varon J, & Marik PE: Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians. Crit Care 2005; 9(2):158-169.
- Hussain TF, Heidenreich PA, & Benowitz N: Recurrent non-Q-wave myocardial infarction associated with toluene abuse. Am Heart J 1996; 131:615-616.
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: 1,3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide), 97, International Agency for Research on Cancer, Lyon, France, 2008.
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol, 88, International Agency for Research on Cancer, Lyon, France, 2006.
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Household Use of Solid Fuels and High-temperature Frying, 95, International Agency for Research on Cancer, Lyon, France, 2010a.
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines, 89, International Agency for Research on Cancer, Lyon, France, 2007.
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Non-heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures, 92, International Agency for Research on Cancer, Lyon, France, 2010.
- IARC: List of all agents, mixtures and exposures evaluated to date - IARC Monographs: Overall Evaluations of Carcinogenicity to Humans, Volumes 1-88, 1972-PRESENT. World Health Organization, International Agency for Research on Cancer. Lyon, FranceAvailable from URL: http://monographs.iarc.fr/monoeval/crthall.html. As accessed Oct 07, 2004.
- ICAO: Technical Instructions for the Safe Transport of Dangerous Goods by Air, 2003-2004. International Civil Aviation Organization, Montreal, Quebec, Canada, 2002.
- ILC Dover, Inc.: Ready 1 The Chemturion Limited Use Chemical Protective Suit, ILC Dover, Inc., Frederica, DE, 1998.
- ILO: Encyclopaedia of Occupational Health and Safety, 3rd ed, Vol 2, International Labour Organization, Geneva, Switzerland, 1983, pp 2184-2185.
- ILO: JM Stellman (ed): Encyclopaedia of Occupational Health and Safety, 4th ed, 1-4, International Labour Organization, Geneva, Switzerland, 1998.
- ITI: Toxic and Hazardous Industrial Chemicals Safety Manual, The International Technical Information Institute, Tokyo, Japan, 1995.
- Ikeda M & Tsukagoshi H: Encephalopathy due to toluene sniffing: report of a case with magnetic resonance imaging. Eur Neurol 1990; 30:347-349.
- Inagaki H: An enzyme-linked immunosorbent assay for hippuric acid: its potential application for biological monitoring of toluene exposure. Internat Arch Occup Environ Health 1994; 66:91-95.
- Inoue O, Seiji K, & Watanabe T: Effects of smoking and drinking on excretion of hippuric acid among toluene-exposed workers. Internat Arch Occup Environ Health 1993; 64:425-430.
- International Agency for Research on Cancer (IARC): IARC monographs on the evaluation of carcinogenic risks to humans: list of classifications, volumes 1-116. International Agency for Research on Cancer (IARC). Lyon, France. 2016. Available from URL: http://monographs.iarc.fr/ENG/Classification/latest_classif.php. As accessed 2016-08-24.
- International Agency for Research on Cancer: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. World Health Organization. Geneva, Switzerland. 2015. Available from URL: http://monographs.iarc.fr/ENG/Classification/. As accessed 2015-08-06.
- Jaeger RW, Scalzo AS, & Thompson MW: ECMO in hydrocarbon aspiration (Abstract). Vet Human Toxicol 1987; 29:485.
- Jones HE & Balster RL: Neurobehavioral consequences of intermittent prenatal exposure to high concentrations of toluene. Neurotoxicol Teratol 1997; 19:305-313.
- Kamijima M, Nakazawa Y, & Yamakawa M: Metabolic acidosis and renal tubular injury due to pure toluene inhalation. Arch Environ Health 1994; 49:410-413.
- Kamijo Y, Soma K, & Hasegawa I: Fatal bilateral adrenal hemorrhage following acute toluene poisoning: a case report. Clin Toxicol 1998; 36:365-368.
- Kappler, Inc.: Suit Smart. Kappler, Inc.. Guntersville, AL. 2001. Available from URL: http://www.kappler.com/suitsmart/smartsuit2/na_english.asp?select=1. As accessed 7/10/2001.
- Karmakar GC & Roxburgh R: Rhabdomyolysis in a glue sniffer. N Z Med J 2008; 121(1271):70-71.
- Kashima T, Fukui M, & Masuda Y: Report of five cases, where an ordinary vinyl bag was used for suicidal purpose. Jpn J Legal Med 1969; 23:248-252.
- Kawai T, Mizunuma K, & Okada Y: Toluene itself as the best urinary marker of toluene exposure. Int Arch Occup Environ Health 1996; 68:289-297.
- Kawamoto T, Koga M, & Murata K: Effects of ALDH2, CYP1A1, and CYP2E1 genetic polymorphisms and smoking and drinking habits on toluene metabolism in humans. Toxicol Appl Pharmacol 1995; 133:295-304.
- Kim H, Wang RS, & Elovaara E: Cytochrome P450 isozymes responsible for the metabolism of toluene and styrene in human liver microsomes. Xenobiotica 1997; 27:657-665.
- Kimberly-Clark, Inc.: Chemical Test Results. Kimberly-Clark, Inc.. Atlanta, GA. 2002. Available from URL: http://www.kc-safety.com/tech_cres.html. As accessed 10/4/2002.
- King PJ, Morris JG, & Pollard JD: Glue sniffing neuropathy. Aust NZ J Med 1985; 15:293-299.
- Kiyokawa M, Mizota A, & Takasoh M: Pattern visual evoked cortical potentials in patients with toxic optic neuropathy caused by toluene abuse. Jpn J Opththalmol 1999; 43:438-442.
- Klimisch H-J, Hellwig J, & Hofmann A: Studies on the prenatal toxicity of toluene in rabbits following inhalation exposure and proposal of a pregnancy guidance value. Arch Toxicol 1992; 66:373-381.
- Knight AT, Pawsey CGK, & Aroney RS: Upholsterers' glue associated with myocarditis, hepatitis, acute renal failure and lymphoma. Med J Aust 1991; 154:360-362.
- Koga T, Kawazu T, Iwashita K, et al: Pulmonary hyperinflation and respiratory distress following solvent aspiration in a patient with asthma: expectoration of bronchial casts and clinical improvement with high-frequency chest wall oscillation. Respir Care 2004; 49:1335-1338.
- Kollef MH & Schuster DP: The acute respiratory distress syndrome. N Engl J Med 1995; 332:27-37.
- Kroeger RM, Moore RJ, & Lehman TH: Recurrent urinary calculi associated with toluene sniffing. J Urol 1980; 123:89-91.
- Kurppa K: Scand J Work Environ Health 1983; 9:89-93.
- LaCrosse-Rainfair: Safety Products, LaCrosse-Rainfair, Racine, WI, 1997.
- Lambert B & Lindblad A: J Toxicol Environ Health 1980; 6:1237-1243.
- Lamont CM & Adams FG: Glue-sniffing as a cause of a positive radio-isotope brain scan. Eur J Nuclear Med 1982; 7:387-388.
- Lapare S, Tardif R, & Brodeur J: Effect of various exposure scenarios on the biological monitoring of organic solvents in alveolar air. 1. Toluene and m-xylene. Internat Arch Occup Environ Health 1993; 64:569-580.
- Larsen F & Leira HL: Organic brain syndrome and long-term exposure to toluene: a clinical, psychiatric study of vocationally active printing workers. J Occup Med 1988; 30:875-878.
- Lataye R, Campo P, Pouyatos B, et al: Solvent ototoxicity in the rat and guinea pig. Neurotoxicol Teratol 2002; 25:39-50.
- Levy NT, O'Neill-Kerr AJ, & Cantrell AC: Masquerading as major depression (letter). SAMJ 1994; 84:363-364.
- Lewis RJ: Hawley's Condensed Chemical Dictionary, 13th ed, John Wiley & Sons, Inc, New York, NY, 1997.
- Lewis RJ: Sax's Dangerous Properties of Industrial Materials, 10th ed, John Wiley & Sons, New York, NY, 2000.
- Lide DR: CRC Handbook of Chemistry and Physics, CRC Press, Boca Raton, FL, 1993.
- Lindemann R: Case report: congenital renal tubular dysfunction associated with maternal sniffing of organic solvents. Acta Paediatr Scand 1991; 80:882-884.
- Litton Bionetics: Teratology study in rats. Med Res Publ No. 26-60019 (cited in Klimisch et al, 1992), American Petroleum Institute, Washington, DC, 1978.
- Liu S-J, Qu Q-S, & Xu X-P: Toluene vapor exposure and urinary excretion of hippuric acid among workers in China. Am J Ind Med 1992; 22:313-323.
- Liu Y, Rao D, & Fechter LD: Correspondence between middle frequency auditory loss in vivo and outer hair cell shortening in vitro. Hear Res 1997; 112:134-40.
- Lof A, Wigaeus Hjelm E, & Colmsjo A: Toxicokinetics of toluene and urinary excretion of hippuric acid after human exposure to H-2(8)-toluene. Br J Ind Med 1993; 50:55-59.
- Lovell RA, Trammel HL, & Beasley VR: A review of 83 reports of suspected toluene/dichlorophen toxicoses in cats and dogs. J Am Animal Hosp Assoc 1990; 26:652-658.
- Luderer U, Morgan MS, & Brodkin CA: Reproductive endocrine effects of acute exposure to toluene in men and women. Occup Environ Med 1999; 56:657-666.
- MAPA Professional: Chemical Resistance Guide. MAPA North America. Columbia, TN. 2003. Available from URL: http://www.mapaglove.com/pro/ChemicalSearch.asp. As accessed 4/21/2003.
- MAPA Professional: Chemical Resistance Guide. MAPA North America. Columbia, TN. 2004. Available from URL: http://www.mapaglove.com/ProductSearch.cfm?id=1. As accessed 6/10/2004.
- Maas E, Ashe J, & Spiegel P: Acquired pendular nystagmus in toluene addiction. Neurology 1991; 41:282-285.
- Machado B, Cross K, & Snodgrass WR: Accidental hydrocarbon ingestion cases telephoned to a regional poison center. Ann Emerg Med 1988; 17:804-807.
- Maestri L, Ghittori S, & Imbriani M: Determination of specific mercapturic acids as an index of exposure to environmental benzene, toluene, and styrene. Ind Health 1997; 35:489-501.
- Maki-Paakkanen J: J Toxicol Environ Health 1980; 6:775-781.
- Mar-Mac Manufacturing, Inc: Product Literature, Protective Apparel, Mar-Mac Manufacturing, Inc., McBee, SC, 1995.
- Marigold Industrial: US Chemical Resistance Chart, on-line version. Marigold Industrial. Norcross, GA. 2003. Available from URL: www.marigoldindustrial.com/charts/uschart/uschart.html. As accessed 4/14/2003.
- McDonald JC, Lavoie J, & Cote R: Chemical exposures at work in early pregnancy and congenital defect: a case-referent study. Br J Ind Med 1987; 44:527-533.
- McGregor D: The genetic toxicology of toluene. Mutat Res 1994; 317:213-228.
- Mee AS & Wright PL: Congestive (dilated) cardiomyopathy in association with solvent abuse. J Roy Soc Med 1980; 73:671-672.
- Memphis Glove Company: Permeation Guide. Memphis Glove Company. Memphis, TN. 2001. Available from URL: http://www.memphisglove.com/permeation.html. As accessed 7/2/2001.
- Meulenbelt J, de Grott G, & Savelkoul TJF: Two cases of acute toluene intoxication. Br J Ind Med 1990; 47:417-420.
- Meulenberg CJW & Vijverberg HPM: Selective inhibition of gamma-aminobutyric acid type A receptors in human IMR-32 cells by low concentrations of toluene. Toxicology 2003; 190:243-248.
- Michon S & Tadeusz HP: Polski Tygodnik Lekarski 1968; 23:1061-1062.
- Michon S: Polski Tygodnik Lekarski 1965; 20:1648-1649.
- Midford R, Rose J, & Fleming DT: Glue: what's really in it for sniffers (letter). Med J Aust 1993; 159:634-635.
- Misra LK, Kofoed L, & Fuller W: Treatment of inhalant abuse with risperidone. J Clin Psychiatry 1999; 60(9):620.
- Miyake H: Neurobehav Toxicol Teratol 1983; 5:541-548.
- Miyazaki T, Kojima T, & Yashiki M: Correlation between 'on admission' blood toluene concentrations and the presence or absence of signs and symptoms in solvent abusers. Forens Sci Internat 1990; 44:169-177.
- Mizutani T, Oohashi N, & Naito H: Myoglobinemia and renal failure in toluene poisoning: a case report. Vet Human Toxicol 1989; 31:448-450.
- Montgomery JH & Welkom LM: Groundwater Chemicals Desk Reference, Lewis Publishers, Inc, Chelsea, MI, 1990.
- Montgomery Safety Products: Montgomery Safety Products Chemical Resistant Glove Guide, Montgomery Safety Products, Canton, OH, 1995.
- Morata TC, Dunn DE, & Sieber WK: Occupational exposure to noise and ototoxic organic solvents. Arch Environ Health 1994; 49:359-365.
- Morata TC, Fiorini AC, & Fischer FM: Toluene-induced hearing loss among rotogravure printing workers. Scand J Work Environ Health 1997; 23:289-298.
- Moretto A & Lotti M: Exposure to toluene increases the urinary excretion of D-glucaric acid. Br J Ind Med 1990; 47:58-61.
- Moss AH, Gabow PA, & Kaehny WD: Fanconi's syndrome and distal renal tubular acidosis after glue sniffing. Ann Intern Med 1980; 92:69-70.
- Murata K, Araki S, & Yokoyama K: Cardiac autonomic dysfunction in rotogravure printers exposed to toluene in relation to peripheral nerve conduction. Ind Health 1993; 31:79-90.
- NFPA: Fire Protection Guide to Hazardous Materials, 12th ed, National Fire Protection Association, Quincy, MA, 1997.
- NFPA: Fire Protection Guide to Hazardous Materials, 13th ed., National Fire Protection Association, Quincy, MA, 2002.
- NHLBI ARDS Network: Mechanical ventilation protocol summary. Massachusetts General Hospital. Boston, MA. 2008. Available from URL: http://www.ardsnet.org/system/files/6mlcardsmall_2008update_final_JULY2008.pdf. As accessed 2013-08-07.
- NIOSH: Pocket Guide to Chemical Hazards. National Institute for Occupational Safety and Health. Cincinnati, OH (Internet Version). Edition expires 2002; provided by Truven Health Analytics Inc., Greenwood Village, CO.
- NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 1, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2001.
- NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 2, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2002.
- NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 3, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2003.
- NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 4, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2004.
- Naradzay J & Barish RA: Approach to ophthalmologic emergencies. Med Clin North Am 2006; 90(2):305-328.
- Nat-Wear: Protective Clothing, Hazards Chart. Nat-Wear. Miora, NY. 2001. Available from URL: http://www.natwear.com/hazchart1.htm. As accessed 7/12/2001.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2,3-Trimethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d68a&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2,4-Trimethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006m. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d68a&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2-Butylene Oxide (Proposed). United States Environmental Protection Agency. Washington, DC. 2008d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648083cdbb&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2-Dibromoethane (Proposed). United States Environmental Protection Agency. Washington, DC. 2007g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064802796db&disposition=attachment&contentType=pdf. As accessed 2010-08-18.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,3,5-Trimethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d68a&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 2-Ethylhexyl Chloroformate (Proposed). United States Environmental Protection Agency. Washington, DC. 2007b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648037904e&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Acrylonitrile (Proposed). United States Environmental Protection Agency. Washington, DC. 2007c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648028e6a3&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Adamsite (Proposed). United States Environmental Protection Agency. Washington, DC. 2007h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Agent BZ (3-quinuclidinyl benzilate) (Proposed). United States Environmental Protection Agency. Washington, DC. 2007f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803ad507&disposition=attachment&contentType=pdf. As accessed 2010-08-18.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Allyl Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2008. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648039d9ee&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Aluminum Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Arsenic Trioxide (Proposed). United States Environmental Protection Agency. Washington, DC. 2007m. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480220305&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Automotive Gasoline Unleaded (Proposed). United States Environmental Protection Agency. Washington, DC. 2009a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cc17&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Biphenyl (Proposed). United States Environmental Protection Agency. Washington, DC. 2005j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064801ea1b7&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Bis-Chloromethyl Ether (BCME) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006n. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648022db11&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Boron Tribromide (Proposed). United States Environmental Protection Agency. Washington, DC. 2008a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803ae1d3&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Bromine Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2007d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648039732a&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Bromoacetone (Proposed). United States Environmental Protection Agency. Washington, DC. 2008e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809187bf&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Calcium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Carbonyl Fluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2008b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803ae328&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Carbonyl Sulfide (Proposed). United States Environmental Protection Agency. Washington, DC. 2007e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648037ff26&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Chlorobenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2008c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803a52bb&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Cyanogen (Proposed). United States Environmental Protection Agency. Washington, DC. 2008f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809187fe&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Dimethyl Phosphite (Proposed). United States Environmental Protection Agency. Washington, DC. 2009. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cbf3&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Diphenylchloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethyl Isocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648091884e&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethyl Phosphorodichloridate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480920347&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2008g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809203e7&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethyldichloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Germane (Proposed). United States Environmental Protection Agency. Washington, DC. 2008j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963906&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Hexafluoropropylene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064801ea1f5&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ketene (Proposed). United States Environmental Protection Agency. Washington, DC. 2007. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ee7c&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Magnesium Aluminum Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Magnesium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Malathion (Proposed). United States Environmental Protection Agency. Washington, DC. 2009k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809639df&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Mercury Vapor (Proposed). United States Environmental Protection Agency. Washington, DC. 2009b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a8a087&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyl Isothiocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963a03&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyl Parathion (Proposed). United States Environmental Protection Agency. Washington, DC. 2008l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963a57&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyl tertiary-butyl ether (Proposed). United States Environmental Protection Agency. Washington, DC. 2007a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064802a4985&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methylchlorosilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2005. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5f4&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyldichloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyldichlorosilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2005a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c646&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Mustard (HN1 CAS Reg. No. 538-07-8) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6cb&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Mustard (HN2 CAS Reg. No. 51-75-2) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6cb&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Mustard (HN3 CAS Reg. No. 555-77-1) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6cb&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Tetroxide (Proposed). United States Environmental Protection Agency. Washington, DC. 2008n. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648091855b&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Trifluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2009l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963e0c&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Parathion (Proposed). United States Environmental Protection Agency. Washington, DC. 2008o. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963e32&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Perchloryl Fluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2009c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e268&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Perfluoroisobutylene (Proposed). United States Environmental Protection Agency. Washington, DC. 2009d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e26a&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phenyl Isocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008p. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096dd58&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phenyl Mercaptan (Proposed). United States Environmental Protection Agency. Washington, DC. 2006d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020cc0c&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phenyldichloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phorate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008q. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096dcc8&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phosgene (Draft-Revised). United States Environmental Protection Agency. Washington, DC. 2009e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a8a08a&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phosgene Oxime (Proposed). United States Environmental Protection Agency. Washington, DC. 2009f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e26d&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Potassium Cyanide (Proposed). United States Environmental Protection Agency. Washington, DC. 2009g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cbb9&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Potassium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Propargyl Alcohol (Proposed). United States Environmental Protection Agency. Washington, DC. 2006e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ec91&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Selenium Hexafluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2006f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ec55&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Silane (Proposed). United States Environmental Protection Agency. Washington, DC. 2006g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d523&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Sodium Cyanide (Proposed). United States Environmental Protection Agency. Washington, DC. 2009h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cbb9&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Sodium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Strontium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Sulfuryl Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2006h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ec7a&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tear Gas (Proposed). United States Environmental Protection Agency. Washington, DC. 2008s. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096e551&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tellurium Hexafluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2009i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e2a1&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tert-Octyl Mercaptan (Proposed). United States Environmental Protection Agency. Washington, DC. 2008r. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096e5c7&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tetramethoxysilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2006j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d632&disposition=attachment&contentType=pdf. As accessed 2010-08-17.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Trimethoxysilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2006i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d632&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Trimethyl Phosphite (Proposed). United States Environmental Protection Agency. Washington, DC. 2009j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7d608&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Trimethylacetyl Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2008t. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096e5cc&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Zinc Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for n-Butyl Isocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008m. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064808f9591&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
- National Asthma Education and Prevention Program: Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007; 120(5 Suppl):S94-S138.
- National Heart,Lung,and Blood Institute: Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart,Lung,and Blood Institute. Bethesda, MD. 2007. Available from URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
- National Institute for Occupational Safety and Health: NIOSH Pocket Guide to Chemical Hazards, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Cincinnati, OH, 2007.
- National Research Council : Acute exposure guideline levels for selected airborne chemicals, 5, National Academies Press, Washington, DC, 2007.
- National Research Council: Acute exposure guideline levels for selected airborne chemicals, 6, National Academies Press, Washington, DC, 2008.
- National Research Council: Acute exposure guideline levels for selected airborne chemicals, 7, National Academies Press, Washington, DC, 2009.
- National Research Council: Acute exposure guideline levels for selected airborne chemicals, 8, National Academies Press, Washington, DC, 2010.
- Nawrot P & Staples R: Embryofetal toxicity and teratogenicity of benzene and toluene in the mouse. Teratology 1979; 19:41a.
- Neese Industries, Inc.: Fabric Properties Rating Chart. Neese Industries, Inc.. Gonzales, LA. 2003. Available from URL: http://www.neeseind.com/new/TechGroup.asp?Group=Fabric+Properties&Family=Technical. As accessed 4/15/2003.
- Neundorfer B & Reinhardt F: Polyneuropathies from solvents. Fortschr Neurol Psychiatr 1998; 66:539-544.
- Ng TP, Foo SC, & Yoong T: Menstrual function in workers exposed to toluene. Br J Ind Med 1992; 49:799-803.
- Ng TP, Ong SG, & Lam Wk: Urinary levels of proteins and metabolites in workers exposed to toluene. A cross-sectional study. Internat Arch Occup Environ Health 1990; 62:43-46.
- Nise G & Orbaek P: Toluene in venous blood during and after work in rotogravure printing. Internat Arch Occup Environ Health 1988; 60:31-35.
- Nise G, Attewell R, & Skerfving S: Br J Ind Med 1989; 46:407-411.
- Nise G, Hogstedt B, & Bratt I: Mutat Res 1991; 261:217-223.
- None Listed: Position paper: cathartics. J Toxicol Clin Toxicol 2004; 42(3):243-253.
- North: Chemical Resistance Comparison Chart - Protective Footwear . North Safety. Cranston, RI. 2002. Available from URL: http://www.linkpath.com/index2gisufrm.php?t=N-USA1. As accessed April 30, 2004.
- North: eZ Guide Interactive Software. North Safety. Cranston, RI. 2002a. Available from URL: http://www.northsafety.com/feature1.htm. As accessed 8/31/2002.
- O'Brien ET, Yeoman WB, & Hobby JAE: Hepatorenal damage from toluene in a "glue sniffer". Br Med J 1971; 2:29-30.
- OHM/TADS : Oil and Hazardous Materials/Technical Assistance Data System. US Environmental Protection Agency. Washington, DC (Internet Version). Edition expires 2002; provided by Truven Health Analytics Inc., Greenwood Village, CO.
- OHM/TADS: Oil and Hazardous Materials/Technical Assistance Data System. US Environmental Protection Agency. Washington, DC (Internet Version). Edition expires 2002; provided by Truven Health Analytics Inc., Greenwood Village, CO.
- Ono A, Kawashima K, & Sekita K: Toluene inhalation induced epididymal sperm dysfunction in rats. Toxicology 1999; 139:193-205.
- Paraf F, Lewis J, & Jothy S: Acute fatty liver of pregnancy after exposure to toluene - a case report. J Clin Gastroenterol 1993; 17:163-165.
- Pearson MA, Hoyme HE, & Seaver LH: Toluene embryopathy - delineation of the phenotype and comparison with fetal alcohol syndrome. Pediatrics 1994; 93:211-215.
- Peate WF: Work-related eye injuries and illnesses. Am Fam Physician 2007; 75(7):1017-1022.
- Pelclova D, Cerna M, & Pastorkova A: Study of the genotoxicity of toluene. Arch Environ Health 2000; 55:268-273.
- Periago JF, Morente A, & Villanueva M: Correlation between concentrations of n-hexane and toluene in exhaled and environmental air in an occupationally exposed population. J Appl Toxicol 1994; 14:63-67.
- Pierce CH, Dills RL, & Morgan MS: Biological monitoring of controlled toluene exposure. Internat Arch Occup Environ Health 1998; 71:433-444.
- Playtex: Fits Tough Jobs Like a Glove, Playtex, Westport, CT, 1995.
- Plenge-Bonig A & Karmaus W: Exposure to toluene in the printing industry is associated with subfecundity in women but not in men. Occup Environ Med 1999; 56:443-448.
- Pohanish RP & Greene SA: Rapid Guide to Chemical Incompatibilities, Van Nostrand Reinhold Company, New York, NY, 1997.
- Polderman KH: Acute renal failure and rhabdomyolysis. Int J Artif Organs 2004; 27(12):1030-1033.
- Pollack MM, Dunbar BS, & Holbrook PR: Aspiration of activated charcoal and gastric contents. Ann Emerg Med 1981; 10:528-529.
- Pryor G, Rebert C, & Kassay K: The hearing loss associated with exposure to toluene is not caused by a metabolite. Brain Res Bull 1991; 27:109-113.
- Pryor GT & Howd RA: Toluene-induced ototoxicity by sub-cutaneous administration. Neurobehav Toxicol Teratol 1986; 8:103-104.
- Pryor GT: Neurobehav Toxicol Teratol 1984; 6:111-119.
- Pryor GT: Neurobehav Toxicol Teratol 1984b; 6:223-238.
- RTECS : Registry of Toxic Effects of Chemical Substances. National Institute for Occupational Safety and Health. Cincinnati, OH (Internet Version). Edition expires 5/31/2002; provided by Truven Health Analytics Inc., Greenwood Village, CO.
- Rabus R & Widdel F: Utilization of alkylbenzenes during anaerobic growth of pure cultures of denitrifying bacteria on crude oil. Appl Environ Microbiol 1996; 62(4):1238-1241.
- Rahill AA, Weiss B, & Morrow PE: Human performance during exposure to toluene. Aviat Space Environ Med 1996; 67:640-647.
- Raikhlin-Eisenkraft B, Hoffer E, Baum Y, et al: Determination of urinary hippuric acid in toluene abuse. J Toxicol Clin Toxicol 2001; 39:73-76.
- Rau NR, Nagaraj MV, Prakash PS, et al: Fatal pulmonary aspiration of oral activated charcoal. Br Med J 1988; 297:918-919.
- Rebert CS: Neurobehav Toxicol Teratol 1983; 5:59-62.
- Reisin E, Teicher A, & Jaffe R: Myoglobinuria and renal failure in toluene poisoning. Br J Ind Med 1975; 32:163-164.
- Reyes de la Roche S, Brown MA, & Fortenberry JD: Pulmonary function abnormalities in intentional spray paint inhalation. Chest 1987; 92:100-104.
- Richer CL, Chakrabarti S, & Senecalquevillon M: Cytogenetic effects of low-level exposure to toluene, xylene, and their mixture on human blood lymphocytes. Internat Arch Occup Environ Health 1993; 64:581-585.
- River City: Protective Wear Product Literature, River City, Memphis, TN, 1995.
- Rosenberg NL, Kleinschmidt-DeMasters BK, & Davis KA: Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol 1988; 23:611-614.
- Ryu YH, Lee JD, & Yoon PH: Cerebral perfusion impairment in a patient with toluene abuse. J Nucl Med 1998; 39:632-633.
- Safety 4: North Safety Products: Chemical Protection Guide. North Safety. Cranston, RI. 2002. Available from URL: http://www.safety4.com/guide/set_guide.htm. As accessed 8/14/2002.
- Saker EG, Eskew AE, & Panter JW: Stability of toluene in blood: its forensic relevance. J Anal Toxicol 1991; 15:246-249.
- Salamanca-Gomez F, Hernandez S, & Palma V: Chromosome abnormalities and sister chromatid exchanges in children with acute intoxication due to inhalation of volatile substances. Arch Environ Health 1989; 44:49-53.
- Schardein JL: Chemically Induced Birth Defects, 3rd ed, Marcel Dekker, Inc, New York, NY, 2000.
- Schmid E: Mutat Res 1985; 142:37-39.
- Seeber A, Schaper M, Zupanic M, et al: Toluene exposure below 50 ppm and cognitive function: a follow-up study with four repeated measurements in rotogravure printing plants . Int Arch Occup Environ Health 2004; 77:1-9.
- Servus: Norcross Safety Products, Servus Rubber, Servus, Rock Island, IL, 1995.
- Shannon M: Toluene. Clinical Toxicology Review 1987; 9 (7).
- Shibata K, Yoshita Y, & Matsumoto H: Extensive chemical burns from toluene. Am J Emerg Med 1994; 12:353-355.
- Shih HT, Yu CL, Wu MT, et al: Subclinical abnormalities in workers with continuous low-level toluene exposure. Toxicol Ind Health 2011; 27(8):691-699.
- Shiomi S, Kuroki T, & Kuroda T: Absence of hepatic uptake of Tc-99m phytate in a man with chronic toluene hepatotoxicity. Clin Nucl Med 1993; 18:655-656.
- Sittig M: Handbook of Toxic and Hazardous Chemicals and Carcinogens, 3rd ed, Noyes Publications, Park Ridge, NJ, 1991.
- Smith KN: NIOSH Contract No 210-81-6011. National Institute for Occupational Safety and Health, 1983.
- Snyder R: Ethel Browning's Toxicity and Metabolism of Industrial Solvents, 2nd ed, Vol 1: Hydrocarbons, Elsevier, New York, NY, 1987a.
- Snyder R: Toluene, In: Ethel Browning's Toxicity and Metabolism of Industrial Solvents, Vol 1, Hydrocarbons, 2nd ed, Elsevier Science Publishing Company, Inc, New York, NY, 1987.
- Spiller HA & Rogers GC: Evaluation of administration of activated charcoal in the home. Pediatrics 2002; 108:E100.
- Standard Safety Equipment: Product Literature, Standard Safety Equipment, McHenry, IL, 1995.
- Stolbach A & Hoffman RS: Respiratory Principles. In: Nelson LS, Hoffman RS, Lewin NA, et al, eds. Goldfrank's Toxicologic Emergencies, 9th ed. McGraw Hill Medical, New York, NY, 2011.
- Streicher HZ, Gabow PA, & Moss AH: Syndromes of toluene sniffing in adults. Ann Intern Med 1981; 94:758-762.
- Sugiyama-Oishi A, Arakawa K, & Araki E: A case of chronic toluene intoxication presenting stimulus-sensitive segmental spinal myoclonus. No To Shinkei 2000; 52:399-403.
- Svensson BG, Nise G, & Erfurth EM: Hormone status in occupational toluene exposure. Am J Indust Med 1992a; 22:99-107.
- Svensson BG, Nise G, & Erfurth EM: Neuroendocrine effects in printing workers exposed to toluene. Br J Indust Med 1992; 49:402-408.
- Syrovadko ON: Gig Tr Prof Zabol 1973; 17:5-8.
- Syrovadko ON: Gig Tr Prof Zabol 1977; 21:15-19.
- Taher SM, Anderson RJ, & McCartney R: Renal tubular acidosis associated with toluene sniffing. N Engl J Med 1974; 290:765-768.
- Takahashi S, Matsubara K, & Hasegawa M: Detection and measurement of S-benzyl-N-acetylcysteine in urine of toluene sniffers using capillary gas chromatography. Arch Toxicol 1993; 67:647-650.
- Takeichi S, Yamada T, & Shikata I: Acute toluene poisoning during painting. Forens Sci Internat 1986; 32:109-115.
- Takeuchi I: Jap J Ind Health 1972; 14:563-581.
- Takeuchi Y & Hisanaga N: The neurotoxicity of toluene: EEG changes in rats exposed to various concentrations. Br J Ind Med 1977; 34:314-324.
- Tap O, Solmaz S, & Polat S: The effect of toluene on the rat ovary - an ultrastructural study. J Submicrosc Cytol Pathol 1996; 28:553-558.
- Taskinen H, Kyyronen P, & Hemminki K: Laboratory work and pregnancy outcome. J Occup Med 1994; 36:311-319.
- Taverner D, Harrison DJ, & Bell GM: Acute renal failure due to interstitial nephritis induced by 'glue-sniffing' with subsequent recovery. Scot Med J 1988; 33:246-247.
- Teelucksingh S, Steer CR, & Thompson CJ: Hypothalamic syndrome and central sleep apnea associated with toluene exposure. Q J Med 1991; 286:185-190.
- Terashi H, Nagata K, & Satoh Y: Hippocampal hypoperfusion underlying dementia due to chronic toluene intoxication. Rinsho Shinkeigaku 1997; 37:1010-1013.
- Thakore S & Murphy N: The potential role of prehospital administration of activated charcoal. Emerg Med J 2002; 19:63-65.
- Tingley: Chemical Degradation for Footwear and Clothing. Tingley. South Plainfield, NJ. 2002. Available from URL: http://www.tingleyrubber.com/tingley/Guide_ChemDeg.pdf. As accessed 10/16/2002.
- Toutant C & Lippmann S: Fetal solvents syndrome (letter). Lancet 1979; 1(8130):1356.
- Toutant C: Fetal solvents syndrome. Lancet 1979; 2:1356-1362.
- Trelleborg-Viking, Inc.: Chemical and Biological Tests (database). Trelleborg-Viking, Inc.. Portsmouth, NH. 2002. Available from URL: http://www.trelleborg.com/protective/. As accessed 10/18/2002.
- Trelleborg-Viking, Inc.: Trellchem Chemical Protective Suits, Interactive manual & Chemical Database. Trelleborg-Viking, Inc.. Portsmouth, NH. 2001.
- Truchon G, Tardif R, & Brodeur J: Gas chromatographic determination of urinary o-cresol for the monitoring of toluene exposure. J Anal Toxicol 1996; 20:309-312.
- Truchon G, Tardif R, & Brodeur J: o-cresol: a good indicator of exposure to low levels of toluene. Appl Occup Environ Hyg 1999; 14:677-681.
- Tsao JH, Hu YH, How CK, et al: Atrioventricular conduction abnormality and hyperchloremic metabolic acidosis in toluene sniffing. J Formos Med Assoc 2011; 110(10):652-654.
- Tuchscherer J & Rehman H : Metabolic acidosis in toluene sniffing. CJEM 2013; 15(4):249-252.
- U.S. Department of Energy, Office of Emergency Management: Protective Action Criteria (PAC) with AEGLs, ERPGs, & TEELs: Rev. 26 for chemicals of concern. U.S. Department of Energy, Office of Emergency Management. Washington, DC. 2010. Available from URL: http://www.hss.doe.gov/HealthSafety/WSHP/Chem_Safety/teel.html. As accessed 2011-06-27.
- U.S. Department of Health and Human Services, Public Health Service, National Toxicology Project : 11th Report on Carcinogens. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. Washington, DC. 2005. Available from URL: http://ntp.niehs.nih.gov/INDEXA5E1.HTM?objectid=32BA9724-F1F6-975E-7FCE50709CB4C932. As accessed 2011-06-27.
- U.S. Environmental Protection Agency: Discarded commercial chemical products, off-specification species, container residues, and spill residues thereof. Environmental Protection Agency's (EPA) Resource Conservation and Recovery Act (RCRA); List of hazardous substances and reportable quantities 2010b; 40CFR(261.33, e-f):77-.
- U.S. Environmental Protection Agency: Integrated Risk Information System (IRIS). U.S. Environmental Protection Agency. Washington, DC. 2011. Available from URL: http://cfpub.epa.gov/ncea/iris/index.cfm?fuseaction=iris.showSubstanceList&list_type=date. As accessed 2011-06-21.
- U.S. Environmental Protection Agency: List of Radionuclides. U.S. Environmental Protection Agency. Washington, DC. 2010a. Available from URL: http://www.gpo.gov/fdsys/pkg/CFR-2010-title40-vol27/pdf/CFR-2010-title40-vol27-sec302-4.pdf. As accessed 2011-06-17.
- U.S. Environmental Protection Agency: List of hazardous substances and reportable quantities. U.S. Environmental Protection Agency. Washington, DC. 2010. Available from URL: http://www.gpo.gov/fdsys/pkg/CFR-2010-title40-vol27/pdf/CFR-2010-title40-vol27-sec302-4.pdf. As accessed 2011-06-17.
- U.S. Environmental Protection Agency: The list of extremely hazardous substances and their threshold planning quantities (CAS Number Order). U.S. Environmental Protection Agency. Washington, DC. 2010c. Available from URL: http://www.gpo.gov/fdsys/pkg/CFR-2010-title40-vol27/pdf/CFR-2010-title40-vol27-part355.pdf. As accessed 2011-06-17.
- U.S. Occupational Safety and Health Administration: Part 1910 - Occupational safety and health standards (continued) Occupational Safety, and Health Administration's (OSHA) list of highly hazardous chemicals, toxics and reactives. Subpart Z - toxic and hazardous substances. CFR 2010 2010; Vol6(SEC1910):7-.
- U.S. Occupational Safety, and Health Administration (OSHA): Process safety management of highly hazardous chemicals. 29 CFR 2010 2010; 29(1910.119):348-.
- Uaki H, Kawai T, & Mizunuma K: Dose-dependent suppression of toluene metabolism by isopropyl alcohol and methyl ethyl ketone after experimental exposure of rats. Toxicol Lett 1995; 81:229-234.
- Ukai H, Watanabe T, & Nakatsuka H: Dose-dependent increase in subjective symptoms among toluene-exposed workers. Environ Res 1993; 60:274-289.
- United States Environmental Protection Agency Office of Pollution Prevention and Toxics: Acute Exposure Guideline Levels (AEGLs) for Vinyl Acetate (Proposed). United States Environmental Protection Agency. Washington, DC. 2006. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6af&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
- Urben PG: Bretherick's Handbook of Reactive Chemical Hazards, Vol 1-2, 6th ed, (CD-ROM version), Butterworth-Heinemann Ltd, Oxford, England, 1999.
- Vanholder R, Sever MS, Erek E, et al: Rhabdomyolysis. J Am Soc Nephrol 2000; 11(8):1553-1561.
- Verschueren K: Handbook of Environmental Data on Organic Chemicals. 4th ed. CD-ROM version. Wiley-Interscience. Hoboken, NJ. 2001.
- Voice TC, Pak D, & Zhao XD: Biological activated carbon in fluidized bed reactors for the treatment of groundwater contaminated with volatile aromatic hydrocarbons. Water Res 1992; 26:1389-1401.
- Voights A & Kaufman CE: Acidosis and other metabolic abnormalities associated with paint sniffing. South Med J 1983; 76:443-452.
- Voights A & Kaufman CE: Metabolic abnormalities associated with paint sniffing. South Med J 1983a; 16:443.
- Vrca A, Bozicevic D, & Karacic V: Visual evoked potentials in individuals exposed to long-term low concentrations of toluene. Arch Toxicol 1995; 69:337-340.
- Vrca A, Karacic V, & Bozicevic D: Brainstem auditory evoked potentials in individuals exposed to long-term low concentrations of toluene. Am J Ind Med 1996; 30:62-66.
- Wallen M: Toxicokinetics of toluene in occupationally exposed volunteers. Scand J Work Environ Health 1986; 12:588-593.
- Walter LA & Catenacci MH: Rhabdomyolysis. Hosp Physician 2008; 44(1):25-31.
- Welch L, Kirshner H, & Heath A: Chronic neuropsychological and neurological impairment following acute exposure to a solvent mixture of toluene and methyl ethyl ketone (MEK). Clin Toxicol 1991; 29:435-445.
- Wells Lamont Industrial: Chemical Resistant Glove Application Chart. Wells Lamont Industrial. Morton Grove, IL. 2002. Available from URL: http://www.wellslamontindustry.com. As accessed 10/31/2002.
- Wiebelt H & Becker N: Mortality in a cohort of toluene exposed employees (rotogravure printing plant workers). J Occup Environ Med 1999; 41:1134-1139.
- Wilkins-Haug L & Gabow PA: Toluene abuse during pregnancy: obstetric complications and perinatal outcomes. Obstet Gynecol 1991; 77:504-509.
- Wilkins-Haug L: Teratogen update: toluene. Teratology 1997; 55:145-151.
- Williams DM: Hearing loss in a glue sniffer. J Otolaryngol 1988; 17:321-324.
- Willson DF, Truwit JD, Conaway MR, et al: The adult calfactant in acute respiratory distress syndrome (CARDS) trial. Chest 2015; 148(2):356-364.
- Wilson DF, Thomas NJ, Markovitz BP, et al: Effect of exogenous surfactant (calfactant) in pediatric acute lung injury. A randomized controlled trial. JAMA 2005; 293:470-476.
- Wiseman M & Banim S: "Glue sniffer's" heart?. Br Med J 1987; 294:739.
- Woertz JR, Kinney KA, & McIntosh ND: Removal of toluene in a vapor-phase bioreactor containing a strain of the dimorphic black yeast lecanii-corni. Biotechnol Bioeng 2001; 75:550-558.
- Workrite: Chemical Splash Protection Garments, Technical Data and Application Guide, W.L. Gore Material Chemical Resistance Guide, Workrite, Oxnard, CA, 1997.
- Xiong L, Matthes JD, & Li J: MR imaging of spray heads - toluene abuse via aerosol paint inhalation. Am J Neuroradiol 1993; 14:1195-1199.
- Yadav JS, Wallace RE, & Reddy CA: Mineralization of mono- and dichlorobenzenes and simultaneous degradation of chloro- and methyl-substituted benzenes by the white rot fungus Phanerochaete chrysosporium. Appl Environ Microbiol 1995; 61:677-680.
- Yamada K: Influence of lacquer thinner and some organic solvents on reproductive and accessory reproductive organs in the male rat. Biol Pharm Bull 1993; 16:425-427.
- Yamanouchi N, Okada S, & Kodama K: White matter changes caused by chronic solvent abuse. Am J Neuroradiol 1995; 16:1643-1649.
- Zavalic M, Mandic Z, & Turk R: Qualitative color vision impairment in toluene-exposed workers. Internat Arch Occup Environ Health 1998a; 71:194-200.
- Zee-Cheng C-S, Mueller CE, & Gibbs HR: Toluene sniffing and severe sinus bradycardia. Ann Intern Med 1985; 103:482.
- Zenz C: Occupational Medicine, 3rd ed, Mosby - Year Book, Inc, St. Louis, MO, 1994.
- de Rosa E: Internat Arch Occup Environ Health 1985; 56:135-145.
- von Oettingen WF, Neal PA, & Donahue DD: The toxicity and potential dangers of toluene - preliminary report. JAMA 1942; 113:578.
|